CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | C4-dicarboxylic acid |
|
Accession: | CHEBI:66873
|
browse the term
|
Definition: | Any dicarboxylic acid that contains four carbon atoms. |
Synonyms: | related_synonym: | C4-dicarboxylic acids |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:61336 |
|
|
|
G |
Folh1 |
folate hydrolase 1 |
affects binding multiple interactions |
ISO |
isospaglumic acid binds to FOLH1 protein [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] |
CTD |
PMID:24508213 |
|
NCBI chr 7:86,716,525...86,776,053
Ensembl chr 7:86,718,977...86,775,943
|
|
|
G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
multiple interactions decreases expression |
EXP ISO |
Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] Artesunate results in decreased expression of ACTA2 mRNA; Artesunate results in decreased expression of ACTA2 protein Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr19:34,240,336...34,255,585
Ensembl chr19:34,241,090...34,255,590
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
affects localization |
ISO |
artesunate affects the localization of AIFM1 protein |
CTD |
PMID:24704559 |
|
NCBI chr X:48,474,944...48,513,563
Ensembl chr X:48,474,944...48,513,563
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:98,148,757...98,323,218
Ensembl chr X:98,148,769...98,323,215
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
Artesunate results in increased expression of ATG12 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr18:46,732,417...46,741,724
Ensembl chr18:46,730,144...46,741,580
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
Artesunate results in increased expression of ATG3 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr16:45,158,829...45,188,538
Ensembl chr16:45,158,785...45,188,538
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Artesunate results in increased expression of ATG5 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr10:44,268,322...44,364,299
Ensembl chr10:44,268,358...44,364,291
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
ISO |
artesunate results in increased expression of BAX protein [1,2-Dimethylhydrazine co-treated with artesunate] results in increased expression of BAX protein |
CTD |
PMID:24704559 PMID:29031619 |
|
NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
ISO |
artesunate results in decreased expression of BCL2 protein [1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein |
CTD |
PMID:24704559 PMID:29031619 |
|
NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
increases response to substance |
ISO |
BST1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:43,818,880...43,843,468
Ensembl chr 5:43,818,885...43,843,986
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
artesunate results in increased activity of CASP3 protein |
CTD |
PMID:19513562 PMID:24704559 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp9 |
caspase 9 |
affects expression |
ISO |
artesunate affects the expression of CASP9 protein |
CTD |
PMID:24704559 |
|
NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
|
|
G |
Cat |
catalase |
increases expression decreases response to substance |
ISO |
artesunate results in increased expression of CAT protein CAT protein results in decreased susceptibility to artesunate |
CTD |
PMID:19513562 PMID:20144594 |
|
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
|
|
G |
Cct2 |
chaperonin containing Tcp1, subunit 2 (beta) |
decreases response to substance |
ISO |
CCT2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:117,050,997...117,063,852
Ensembl chr10:117,051,001...117,063,814
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Artesunate results in increased phosphorylation of CHEK1 protein APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein] |
CTD |
PMID:31664825 |
|
NCBI chr 9:36,708,482...36,726,658
Ensembl chr 9:36,708,482...36,727,065
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:31664825 |
|
NCBI chr 5:110,839,800...110,874,140
Ensembl chr 5:110,839,979...110,874,145
|
|
G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
increases response to substance |
ISO |
CLIP4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr17:71,769,674...71,864,210
Ensembl chr17:71,768,473...71,864,273
|
|
G |
Coq8a |
coenzyme Q8A |
decreases response to substance |
ISO |
COQ8A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:180,165,238...180,196,020
Ensembl chr 1:180,165,238...180,199,602
|
|
G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
multiple interactions |
ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 9:120,933,400...120,960,507
Ensembl chr 9:120,929,216...120,960,507
|
|
G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
affects metabolic processing |
ISO |
CYP2A6 protein affects the metabolism of Artesunate |
CTD |
PMID:12920490 |
|
NCBI chr 7:26,835,339...26,843,264
Ensembl chr 7:26,835,305...26,843,548
|
|
G |
Dbh |
dopamine beta hydroxylase |
increases response to substance |
ISO |
DBH mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 2:27,165,507...27,183,204
Ensembl chr 2:27,165,233...27,183,200
|
|
G |
Des |
desmin |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of DES mRNA; Artesunate results in decreased expression of DES protein Deferoxamine inhibits the reaction [Artesunate results in decreased expression of DES mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr 1:75,360,292...75,368,579
Ensembl chr 1:75,360,329...75,368,579
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr10:4,611,989...5,005,633
Ensembl chr10:4,611,593...5,005,614
|
|
G |
Fas |
Fas (TNF receptor superfamily member 6) |
increases expression |
ISO |
artesunate results in increased expression of FAS protein |
CTD |
PMID:19513562 |
|
NCBI chr19:34,290,647...34,327,775
Ensembl chr19:34,290,666...34,327,772
|
|
G |
Flna |
filamin, alpha |
increases response to substance |
ISO |
FLNA mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr X:74,223,461...74,249,854
Ensembl chr X:74,223,461...74,249,820
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of FN1 mRNA] Artesunate results in decreased expression of FN1 mRNA; Artesunate results in decreased expression of FN1 protein |
CTD |
PMID:30551460 |
|
NCBI chr 1:71,585,473...71,653,280
Ensembl chr 1:71,585,520...71,653,200
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of FTH1 mRNA; Artesunate results in decreased expression of FTH1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr19:9,980,600...9,985,111
Ensembl chr19:9,980,598...9,985,098
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases response to substance |
ISO |
FZD7 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:59,482,147...59,486,955
Ensembl chr 1:59,482,424...59,486,955
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects response to substance decreases response to substance |
ISO |
GCLC mRNA affects the susceptibility to artesunate GCLC mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
decreases response to substance |
ISO |
GCLM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions decreases activity |
EXP ISO |
Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX4 protein] Artesunate results in decreased activity of GPX4 protein |
CTD |
PMID:30551460 |
|
NCBI chr10:80,047,166...80,056,439
Ensembl chr10:80,047,166...80,056,439
|
|
G |
Gstm4 |
glutathione S-transferase, mu 4 |
affects response to substance |
ISO |
GSTM4 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 3:108,030,571...108,045,179
Ensembl chr 3:108,040,408...108,044,894
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
decreases expression |
ISO |
artesunate results in decreased expression of GSTP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
|
|
G |
Gstz1 |
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
affects response to substance |
ISO |
GSTZ1 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr12:87,147,161...87,164,723
Ensembl chr12:87,147,165...87,164,723
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
artesunate inhibits the reaction [Ethanol results in increased expression of IL1B protein]; artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL6 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 5:30,013,114...30,019,975
Ensembl chr 5:30,013,114...30,019,981
|
|
G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
increases response to substance |
ISO |
ITGB1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 8:128,685,654...128,733,579
Ensembl chr 8:128,685,654...128,733,200
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
affects response to substance |
ISO |
MGST3 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 1:167,371,966...167,393,841
Ensembl chr 1:167,371,966...167,393,841
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
multiple interactions |
ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 7:135,689,784...135,716,450
Ensembl chr 7:135,689,784...135,716,361
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] |
CTD |
PMID:29031619 PMID:30551460 |
|
NCBI chr 2:164,940,326...164,955,850
Ensembl chr 2:164,940,780...164,955,850
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
artesunate inhibits the reaction [Ethanol results in increased activity of MPO protein] |
CTD |
PMID:27474069 |
|
NCBI chr11:87,793,784...87,804,412
Ensembl chr11:87,793,581...87,804,413
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
decreases response to substance |
ISO |
MTHFD2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 6:83,305,704...83,326,011
Ensembl chr 6:83,305,691...83,325,908
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
multiple interactions |
ISO |
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 9:119,335,934...119,340,018
Ensembl chr 9:119,335,934...119,341,411
|
|
G |
Naca |
nascent polypeptide-associated complex alpha polypeptide |
decreases response to substance |
ISO |
NACA mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:128,035,346...128,048,637
Ensembl chr10:128,035,575...128,048,637
|
|
G |
Nckap1 |
NCK-associated protein 1 |
increases response to substance |
ISO |
NCKAP1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 2:80,500,512...80,581,182
Ensembl chr 2:80,500,512...80,581,380
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA] Artesunate results in decreased expression of NCOA4 mRNA; Artesunate results in decreased expression of NCOA4 protein |
CTD |
PMID:30551460 |
|
NCBI chr14:32,159,879...32,179,855
Ensembl chr14:32,159,865...32,179,855
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization |
ISO |
artesunate affects the localization of NFE2L2 protein |
CTD |
PMID:26340163 |
|
NCBI chr 2:75,675,513...75,704,663
Ensembl chr 2:75,675,513...75,704,641
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein] |
CTD |
PMID:30031708 |
|
NCBI chr11:59,541,569...59,566,955
Ensembl chr11:59,541,568...59,566,956
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
artesunate results in increased cleavage of PARP1 protein |
CTD |
PMID:24704559 |
|
NCBI chr 1:180,568,891...180,600,999
Ensembl chr 1:180,568,924...180,601,254
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 2:132,249,286...132,253,180
Ensembl chr 2:132,249,162...132,253,314
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
artesunate binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 9:8,898,900...8,968,611
Ensembl chr 9:8,899,833...8,968,611
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 mRNA; [Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 protein |
CTD |
PMID:30551460 |
|
NCBI chr 1:150,100,031...150,108,234
Ensembl chr 1:150,100,031...150,108,227
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
artesunate inhibits the reaction [Ethanol results in increased expression of RELA protein]; artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr19:5,637,442...5,648,134
Ensembl chr19:5,637,483...5,648,130
|
|
G |
Rpa2 |
replication protein A2 |
increases phosphorylation |
ISO |
Artesunate results in increased phosphorylation of RPA2 protein |
CTD |
PMID:31664825 |
|
NCBI chr 4:132,768,360...132,778,746
Ensembl chr 4:132,768,332...132,778,752
|
|
G |
Rpl41 |
ribosomal protein L41 |
decreases response to substance |
ISO |
RPL41 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:128,548,110...128,549,168
Ensembl chr10:128,548,114...128,549,305
|
|
G |
Rpl6 |
ribosomal protein L6 |
decreases response to substance |
ISO |
RPL6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:121,204,501...121,209,241
Ensembl chr 5:121,204,481...121,209,241
|
|
G |
Rpl7 |
ribosomal protein L7 |
decreases response to substance |
ISO |
RPL7 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:16,101,295...16,104,433
Ensembl chr 1:16,101,295...16,104,662
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases response to substance |
ISO |
RPS12 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:23,785,183...23,787,383
Ensembl chr10:23,785,183...23,787,275
|
|
G |
Rps15a |
ribosomal protein S15A |
decreases response to substance |
ISO |
RPS15A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:118,104,374...118,116,147
Ensembl chr 7:118,104,372...118,116,188
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases response to substance |
ISO |
RPS6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 4:86,854,099...86,857,367
Ensembl chr 4:86,854,660...86,857,412
|
|
G |
Slc25a19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
decreases response to substance |
ISO |
SLC25A19 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr11:115,614,165...115,628,296
Ensembl chr11:115,614,178...115,628,295
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
decreases expression |
ISO |
artesunate results in decreased expression of SP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr15:102,406,316...102,436,404
Ensembl chr15:102,406,143...102,436,404
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of SQSTM1 mRNA; Artesunate results in decreased expression of SQSTM1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein] |
CTD |
PMID:30551460 |
|
NCBI chr11:50,200,152...50,210,820
Ensembl chr11:50,199,366...50,210,827
|
|
G |
Srsf2 |
serine and arginine-rich splicing factor 2 |
decreases response to substance |
ISO |
SRSF2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr11:116,849,897...116,853,675
Ensembl chr11:116,849,901...116,853,094
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
multiple interactions increases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr X:20,870,166...20,874,737
Ensembl chr X:20,870,166...20,874,735
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 4:66,827,551...66,846,581
Ensembl chr 4:66,827,584...66,930,284
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
artesunate inhibits the reaction [Ethanol results in increased expression of TNF protein]; artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects response to substance |
ISO |
TPT1 protein affects the susceptibility to artesunate |
CTD |
PMID:15878303 |
|
NCBI chr14:75,845,256...75,848,303
Ensembl chr14:75,845,093...75,848,525
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
decreases response to substance |
ISO |
TUFM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:126,487,271...126,490,731
Ensembl chr 7:126,487,361...126,490,731
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein] |
CTD |
PMID:29031619 |
|
NCBI chr17:46,016,993...46,032,377
Ensembl chr17:46,016,993...46,032,369
|
|
G |
Yy1 |
YY1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of YY1 protein |
CTD |
PMID:19513562 |
|
NCBI chr12:108,792,945...108,820,148
Ensembl chr12:108,792,973...108,820,148
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
increases response to substance |
ISO |
ZBTB4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr11:69,765,912...69,784,026
Ensembl chr11:69,765,912...69,784,023
|
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCA1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:8,893,614...8,959,226
Ensembl chr 5:8,893,717...8,959,231
|
|
G |
Abcd1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ABCD1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:73,716,597...73,738,534
Ensembl chr X:73,716,597...73,738,534
|
|
G |
Abcd2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:91,145,871...91,192,007
Ensembl chr15:91,145,871...91,191,799
|
|
G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACAA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:119,341,028...119,350,296
Ensembl chr 9:119,339,676...119,350,299
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:119,148,043...119,157,093
Ensembl chr 9:119,148,023...119,157,093
|
|
G |
Acacb |
acetyl-Coenzyme A carboxylase beta |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACACB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:114,146,321...114,250,761
Ensembl chr 5:114,146,535...114,250,761
|
|
G |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADS mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADS mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:115,110,299...115,119,346
Ensembl chr 5:115,110,299...115,119,346
|
|
G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:70,010,183...70,015,428
Ensembl chr11:70,010,183...70,015,411
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO |
Aspartame metabolite results in decreased activity of ACHE protein |
CTD |
PMID:16129618 PMID:17580119 PMID:17673349 |
|
NCBI chr 5:137,288,247...137,294,466
Ensembl chr 5:137,287,519...137,294,466
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:40,143,265...40,199,009
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACOT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:84,009,502...84,017,670
Ensembl chr12:84,009,490...84,018,371
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ADGRE1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:57,358,581...57,483,529
Ensembl chr17:57,358,691...57,483,527
|
|
G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
decreases expression |
ISO |
Aspartame results in decreased expression of AGT mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 8:124,556,587...124,569,706
Ensembl chr 8:124,556,534...124,569,706
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
Aspartame results in decreased expression of AGTR1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr13:30,336,356...30,382,867
Ensembl chr13:30,336,441...30,382,867
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ALOX15 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:70,344,147...70,390,538
Ensembl chr11:70,344,152...70,352,031
|
|
G |
Apoe |
apolipoprotein E |
decreases expression |
ISO |
Aspartame results in decreased expression of APOE mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 7:19,696,244...19,701,310
Ensembl chr 7:19,696,109...19,699,188
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO EXP |
[Aspartame co-treated with Methotrexate] results in increased expression of BAX mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of BAX protein [Fats, Unsaturated co-treated with Aspartame] affects the expression of BAX mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of BAX mRNA |
CTD |
PMID:23783067 PMID:25009784 |
|
NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA; [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein |
CTD |
PMID:25009784 |
|
NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
|
|
G |
Cabp2 |
calcium binding protein 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CABP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CABP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:4,081,469...4,087,340
Ensembl chr19:4,081,578...4,087,340
|
|
G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:84,338,631...84,640,251
Ensembl chr 8:84,338,639...84,640,246
|
|
G |
Cacna1i |
calcium channel, voltage-dependent, alpha 1I subunit |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1I mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1I mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:80,287,238...80,398,292
Ensembl chr15:80,287,238...80,398,279
|
|
G |
Cacna2d4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA2D4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA2D4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:119,236,524...119,352,407
Ensembl chr 6:119,236,526...119,352,407
|
|
G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:14,603,861...14,988,811
Ensembl chr 2:14,603,088...14,987,908
|
|
G |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:107,732,357...107,794,706
Ensembl chr11:107,732,357...107,794,557
|
|
G |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:3,394,042...3,416,266
Ensembl chr 7:3,390,683...3,415,648
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALHM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALHM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:47,132,232...47,138,294
Ensembl chr19:47,105,353...47,138,294
|
|
G |
Calr3 |
calreticulin 3 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALR3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALR3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:72,424,176...72,443,819
Ensembl chr 8:72,424,176...72,443,870
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CANT1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CANT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:118,406,289...118,419,134
Ensembl chr11:118,406,289...118,419,086
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Aspartame co-treated with Methotrexate] results in increased expression of CASP3 mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of CASP3 protein modified form |
CTD |
PMID:25009784 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CASP9 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CASP9 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
[Aspartame co-treated with Methotrexate] results in increased activity of CAT protein |
CTD |
PMID:25009784 |
|
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of CCL2 protein; [Sodium Glutamate co-treated with Aspartame] inhibits the reaction [Fats, Unsaturated results in increased expression of CCL2 protein] |
CTD |
PMID:23783067 |
|
NCBI chr11:82,035,577...82,037,452
Ensembl chr11:82,035,571...82,037,453
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:134,920,401...134,925,525
Ensembl chr 6:134,920,401...134,925,513
|
|
G |
Cherp |
calcium homeostasis endoplasmic reticulum protein |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:72,460,483...72,475,233
Ensembl chr 8:72,460,489...72,475,226
|
|
G |
Cmc1 |
COX assembly mitochondrial protein 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:118,063,983...118,150,196
Ensembl chr 9:118,064,522...118,150,177
|
|
G |
Cox11 |
cytochrome c oxidase assembly protein 11, copper chaperone |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:90,638,184...90,645,977
Ensembl chr11:90,638,173...90,644,931
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX7A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX7A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:30,184,171...30,186,030
Ensembl chr 7:30,184,144...30,186,078
|
|
G |
Cox8b |
cytochrome c oxidase subunit 8B |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX8B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX8B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:140,898,942...140,900,446
Ensembl chr 7:140,898,945...140,900,446
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CPT1B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:89,416,405...89,425,862
Ensembl chr15:89,416,405...89,425,863
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:44,958,483...44,974,880
Ensembl chr 7:44,959,372...44,974,851
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CREB1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:64,532,794...64,604,548
Ensembl chr 1:64,532,645...64,604,548
|
|
G |
Csf1 |
colony stimulating factor 1 (macrophage) |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CSF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:107,741,048...107,760,469
Ensembl chr 3:107,741,048...107,760,469
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity |
ISO |
Aspartame results in increased activity of CYP1A1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 9:57,687,928...57,703,824
Ensembl chr 9:57,687,928...57,703,824
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity |
ISO |
Aspartame results in increased activity of CYP1A2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 9:57,676,937...57,683,655
Ensembl chr 9:57,676,937...57,683,703
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
multiple interactions |
ISO |
Aspartame results in increased expression of and results in increased activity of CYP2B1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 7:25,897,658...25,926,624
Ensembl chr 7:25,897,620...25,926,624
|
|
G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
increases activity |
ISO |
Aspartame results in increased activity of CYP2B2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 7:26,061,388...26,096,197
Ensembl chr 7:26,061,497...26,096,197
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
Aspartame results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 7:140,763,819...140,774,990
Ensembl chr 7:140,763,739...140,774,987
|
|
G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CYP4A10 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:115,518,287...115,533,649
Ensembl chr 4:115,518,264...115,533,649
|
|
G |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CYP4A14 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:115,486,200...115,496,158
Ensembl chr 4:115,486,200...115,496,142
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DIABLO mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DIABLO mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:123,511,330...123,524,164
Ensembl chr 5:123,509,765...123,524,176
|
|
G |
Dnajc27 |
DnaJ heat shock protein family (Hsp40) member C27 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DNAJC27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DNAJC27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:4,082,569...4,124,140
Ensembl chr12:4,082,583...4,110,606
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of E2F1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of E2F1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:154,559,400...154,569,892
Ensembl chr 2:154,559,407...154,569,892
|
|
G |
Edn2 |
endothelin 2 |
decreases expression |
ISO |
Aspartame results in decreased expression of EDN2 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 4:120,161,206...120,167,360
Ensembl chr 4:120,161,206...120,167,360
|
|
G |
Ednra |
endothelin receptor type A |
decreases expression |
ISO |
Aspartame results in decreased expression of EDNRA mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 8:77,663,029...77,724,452
Ensembl chr 8:77,663,031...77,724,464
|
|
G |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EHHADH mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EHHADH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:21,761,285...21,787,834
Ensembl chr16:21,761,287...21,787,807
|
|
G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EPHX2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EPHX2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:66,084,372...66,124,522
Ensembl chr14:66,084,374...66,124,500
|
|
G |
F2 |
coagulation factor II |
decreases activity |
ISO |
Aspartame analog results in decreased activity of F2 protein; Aspartame results in decreased activity of F2 protein |
CTD |
PMID:15572260 |
|
NCBI chr 2:91,612,397...91,636,457
Ensembl chr 2:91,625,320...91,636,414
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
Aspartame results in increased expression of FGF1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr18:38,838,672...38,929,470
Ensembl chr18:38,838,673...38,929,472
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of FOXO3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:42,181,845...42,276,695
Ensembl chr10:42,181,841...42,276,755
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GADD45B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:80,930,091...80,932,204
Ensembl chr10:80,930,073...80,932,204
|
|
G |
Gfm2 |
G elongation factor, mitochondrial 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of GFM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GFM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:97,137,933...97,181,202
Ensembl chr13:97,137,937...97,181,195
|
|
G |
Gip |
gastric inhibitory polypeptide |
multiple interactions |
EXP |
Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]; Sodium Glutamate inhibits the reaction [Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]] |
CTD |
PMID:23783067 |
|
NCBI chr11:96,024,532...96,030,831
Ensembl chr11:96,024,545...96,030,831
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
ISO |
[Aspartame co-treated with Methotrexate] results in decreased activity of GSR protein |
CTD |
PMID:25009784 |
|
NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:30,119,423...30,154,980
Ensembl chr 5:30,118,304...30,155,162
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:30,155,253...30,184,593
Ensembl chr 5:30,155,248...30,184,593
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:129,516,104...129,542,646
Ensembl chr 4:129,516,104...129,542,713
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:102,195,747...102,230,172
Ensembl chr11:102,194,432...102,230,166
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HGF mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:16,553,495...16,619,439
Ensembl chr 5:16,553,495...16,620,152
|
|
G |
Hras |
Harvey rat sarcoma virus oncogene |
increases expression |
EXP |
Aspartame results in increased expression of HRAS |
CTD |
PMID:17354619 |
|
NCBI chr 7:141,189,934...141,194,019
Ensembl chr 7:141,189,105...141,194,005
|
|
G |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:137,468,751...137,570,630
Ensembl chr 4:137,468,769...137,570,630
|
|
G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:80,094,845...80,118,608
Ensembl chr 7:80,094,846...80,115,392
|
|
G |
Il11 |
interleukin 11 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL11 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 7:4,772,373...4,782,907
Ensembl chr 7:4,772,373...4,782,859
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Aspartame results in increased expression of IL1B mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL3 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr11:54,265,085...54,267,279
Ensembl chr11:54,265,303...54,267,277
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
Aspartame results in increased secretion of IL6 protein |
CTD |
PMID:20837131 |
|
NCBI chr 5:30,013,114...30,019,975
Ensembl chr 5:30,013,114...30,019,981
|
|
G |
Immt |
inner membrane protein, mitochondrial |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IMMT mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IMMT mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:71,831,091...71,875,266
Ensembl chr 6:71,831,331...71,877,388
|
|
G |
Ins2 |
insulin II |
increases expression multiple interactions |
ISO EXP |
Aspartame results in increased expression of INS protein [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] results in increased expression of INS2 protein; Aspartame inhibits the reaction [Fats, Unsaturated results in increased expression of INS2 protein] |
CTD |
PMID:1805284 PMID:23783067 |
|
NCBI chr 7:142,678,656...142,679,726
Ensembl chr 7:142,678,656...142,743,381
|
|
G |
Kdr |
kinase insert domain protein receptor |
increases secretion |
ISO |
Aspartame results in increased secretion of KDR protein |
CTD |
PMID:20837131 |
|
NCBI chr 5:75,932,827...75,979,072
Ensembl chr 5:75,932,827...75,978,458
|
|
G |
Lep |
leptin |
decreases expression multiple interactions |
ISO EXP |
Aspartame results in decreased expression of LEP protein [Fats, Unsaturated co-treated with Aspartame] results in increased expression of LEP protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein] |
CTD |
PMID:11890951 PMID:23783067 |
|
NCBI chr 6:29,060,221...29,073,876
Ensembl chr 6:29,060,220...29,073,877
|
|
G |
Lipg |
lipase, endothelial |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LIPG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:74,939,322...74,961,263
Ensembl chr18:74,939,322...74,961,263
|
|
G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:127,538,157...127,621,148
Ensembl chr10:127,538,161...127,621,148
|
|
G |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:69,424,335...69,586,029
Ensembl chr 2:69,424,340...69,586,065
|
|
G |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:91,457,456...91,513,901
Ensembl chr 2:91,457,511...91,513,779
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20837131 |
|
NCBI chr16:16,983,382...17,047,453
Ensembl chr16:16,983,382...17,047,453
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20837131 |
|
NCBI chr 7:126,759,626...126,765,816
Ensembl chr 7:126,759,601...126,765,819
|
|
G |
Mcu |
mitochondrial calcium uniporter |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MCU mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MCU mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:59,446,984...59,617,409
Ensembl chr10:59,446,984...59,616,692
|
|
G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:117,688,875...117,710,758
Ensembl chr10:117,688,875...117,710,758
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MED23 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:24,869,986...24,913,529
Ensembl chr10:24,869,986...24,913,681
|
|
G |
Mef2d |
myocyte enhancer factor 2D |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MEF2D mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:88,141,941...88,172,091
Ensembl chr 3:88,142,372...88,172,086
|
|
G |
Micos10 |
mitochondrial contact site and cristae organizing system subunit 10 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MINOS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MINOS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:139,101,814...139,131,113
Ensembl chr 4:139,101,814...139,131,113
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MICU1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MICU1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:59,702,563...59,864,134
Ensembl chr10:59,702,477...59,864,132
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL20 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL20 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:155,802,878...155,808,831
Ensembl chr 4:155,802,878...155,809,975
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:105,053,268...105,077,466
Ensembl chr 9:105,053,239...105,079,888
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:28,739,641...28,741,821
Ensembl chr 7:28,739,641...28,741,820
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:5,703,982...5,707,701
Ensembl chr11:5,703,983...5,715,680
|
|
G |
Mrps27 |
mitochondrial ribosomal protein S27 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:99,344,767...99,415,562
Ensembl chr13:99,344,786...99,415,562
|
|
G |
Mrps7 |
mitchondrial ribosomal protein S7 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:115,604,140...115,608,036
Ensembl chr11:115,603,925...115,608,036
|
|
G |
Mtfp1 |
mitochondrial fission process 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MTFP1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MTFP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:4,091,481...4,095,431
Ensembl chr11:4,091,480...4,095,445
|
|
G |
Myc |
myelocytomatosis oncogene |
increases expression |
EXP |
Aspartame results in increased expression of MYC |
CTD |
PMID:17354619 |
|
NCBI chr15:61,985,341...61,990,361
Ensembl chr15:61,985,391...61,990,374
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NCOR1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:62,315,663...62,457,414
Ensembl chr11:62,316,426...62,458,541
|
|
G |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:94,199,035...94,221,440
Ensembl chr10:94,198,720...94,221,443
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:24,518,662...24,527,690
Ensembl chr 6:24,518,666...24,528,013
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB10 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB10 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:24,722,060...24,724,423
Ensembl chr17:24,722,060...24,724,478
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:39,592,565...39,599,843
Ensembl chr 6:39,592,574...39,603,382
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:40,270,591...40,279,421
Ensembl chr 4:40,270,591...40,279,421
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:63,143,592...63,176,822
Ensembl chr 1:63,143,596...63,176,833
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase core subunit S6 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:73,319,876...73,328,482
Ensembl chr13:73,319,838...73,328,542
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFV1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFV1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:4,007,499...4,012,755
Ensembl chr19:4,007,384...4,012,806
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:79,339,590...79,581,609
Ensembl chr11:79,339,693...79,581,612
|
|
G |
Notch1 |
notch 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOTCH1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:26,457,902...26,503,822
Ensembl chr 2:26,457,903...26,516,663
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:134,086,421...134,137,711
Ensembl chr X:134,086,421...134,221,956
|
|
G |
Nppb |
natriuretic peptide type B |
decreases expression |
ISO |
Aspartame results in decreased expression of NPPB mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 4:147,985,786...147,987,205
Ensembl chr 4:147,985,788...147,987,205
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
ISO |
Aspartame results in decreased expression of NPY protein |
CTD |
PMID:11890951 |
|
NCBI chr 6:49,822,710...49,829,507
Ensembl chr 6:49,822,710...49,829,507
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NR1I3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:171,213,934...171,218,845
Ensembl chr 1:171,213,970...171,220,701
|
|
G |
Onecut1 |
one cut domain, family member 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ONECUT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:74,861,921...74,889,648
Ensembl chr 9:74,861,921...74,891,781
|
|
G |
Pdha2 |
pyruvate dehydrogenase E1 alpha 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHA2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHA2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:141,210,004...141,212,355
Ensembl chr 3:141,210,004...141,212,355
|
|
G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:8,165,991...8,173,303
Ensembl chr14:8,165,996...8,173,025
|
|
G |
Pex1 |
peroxisomal biogenesis factor 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:3,596,066...3,637,230
Ensembl chr 5:3,596,066...3,637,232
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX11A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX11A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:79,735,957...79,743,131
Ensembl chr 7:79,735,957...79,743,131
|
|
G |
Pex13 |
peroxisomal biogenesis factor 13 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:23,646,843...23,665,883
Ensembl chr11:23,646,479...23,665,959
|
|
G |
Pex5 |
peroxisomal biogenesis factor 5 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:124,396,816...124,415,944
Ensembl chr 6:124,396,816...124,415,067
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:19,860,090...19,907,674
Ensembl chr10:19,853,900...19,907,689
|
|
G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:130,689,043...130,729,253
Ensembl chr 1:130,689,182...130,729,253 Ensembl chr 1:130,689,182...130,729,253
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:108,988,272...109,032,236
Ensembl chr 9:108,991,778...109,032,228
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:70,539,492...70,558,110
Ensembl chr11:70,540,064...70,558,110
|
|
G |
Plg |
plasminogen |
decreases expression |
ISO |
Aspartame results in decreased expression of PLG mRNA |
CTD |
PMID:31655124 |
|
NCBI chr17:12,378,609...12,419,384
Ensembl chr17:12,378,608...12,419,385
|
|
G |
Plxnd1 |
plexin D1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLXND1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:115,954,811...115,995,339
Ensembl chr 6:115,954,811...115,995,005
|
|
G |
Polg |
polymerase (DNA directed), gamma |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of POLG mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of POLG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:79,446,231...79,467,911
Ensembl chr 7:79,446,231...79,466,362
|
|
G |
Pomc |
pro-opiomelanocortin-alpha |
increases expression |
ISO |
Aspartame results in increased expression of POMC protein alternative form |
CTD |
PMID:1805284 |
|
NCBI chr12:3,954,945...3,960,643
Ensembl chr12:3,954,951...3,960,642
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:85,734,910...85,806,851
Ensembl chr15:85,734,983...85,802,819
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:28,232,754...28,301,469
Ensembl chr17:28,232,700...28,301,474
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:115,360,879...115,490,404
Ensembl chr 6:115,360,951...115,490,399
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARGC1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARGC1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:51,454,249...52,115,853
Ensembl chr 5:51,454,250...51,567,726
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PRDX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PRDX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:6,906,697...6,910,106
Ensembl chr19:6,906,697...6,910,106
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ROCK1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:10,064,401...10,182,251
Ensembl chr18:10,064,401...10,182,045
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:90,514,233...90,524,581
Ensembl chr 3:90,514,435...90,524,581
|
|
G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:90,669,071...90,670,034
Ensembl chr 3:90,668,978...90,670,035
|
|
G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:140,961,271...140,979,198
Ensembl chr 4:140,961,203...140,979,193
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:63,319,005...63,339,035
Ensembl chr10:63,319,005...63,381,704
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:28,766,752...28,788,665
Ensembl chr 7:28,766,735...28,788,661
|
|
G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
decreases activity |
ISO |
Aspartame results in decreased activity of SLC15A1 protein |
CTD |
PMID:15846457 |
|
NCBI chr14:121,459,621...121,505,254
Ensembl chr14:121,459,621...121,505,252
|
|
G |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC4A2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:24,423,761...24,440,947
Ensembl chr 5:24,423,837...24,440,950
|
|
G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SLC8A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC8A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:81,373,105...81,738,387
Ensembl chr17:81,373,105...81,738,377
|
|
G |
Srebf2 |
sterol regulatory element binding factor 2 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SREBF2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:82,147,269...82,205,379
Ensembl chr15:82,147,181...82,205,379
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of STAT3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:100,886,806...100,939,594
Ensembl chr11:100,885,098...100,939,540
|
|
G |
Surf1 |
surfeit gene 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:26,913,378...26,916,610
Ensembl chr 2:26,913,381...26,916,530
|
|
G |
Tas1r2 |
taste receptor, type 1, member 2 |
multiple interactions affects binding |
ISO |
Aspartame binds to and results in increased activity of TAS1R2 protein; lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein]; Aspartame binds to TAS1R2 protein |
CTD |
PMID:15353592 PMID:17168764 PMID:17935609 PMID:20173092 |
|
NCBI chr 4:139,653,538...139,670,280
Ensembl chr 4:139,653,538...139,670,280
|
|
G |
Tas1r3 |
taste receptor, type 1, member 3 |
affects binding multiple interactions |
ISO |
Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein] lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] |
CTD |
PMID:17168764 PMID:17935609 |
|
NCBI chr 4:155,859,268...155,863,353
Ensembl chr 4:155,859,268...155,863,362
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TFAM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TFAM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:71,225,468...71,238,328
Ensembl chr10:71,225,464...71,238,280
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of THBS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:118,111,876...118,127,133
Ensembl chr 2:118,111,876...118,127,133
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of TNF protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of TNF protein] |
CTD |
PMID:23783067 |
|
NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression multiple interactions |
EXP |
Aspartame results in increased expression of TRP53 [Fats, Unsaturated co-treated with Aspartame] affects the expression of TRP53 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TRP53 mRNA |
CTD |
PMID:17354619 PMID:23783067 |
|
NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases activity |
ISO |
Aspartame results in increased activity of TRPV1 protein |
CTD |
PMID:17567713 PMID:18804451 |
|
NCBI chr11:73,234,149...73,261,322
Ensembl chr11:73,234,292...73,261,242
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:126,487,271...126,490,731
Ensembl chr 7:126,487,361...126,490,731
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UCP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UCP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:100,493,337...100,499,629
Ensembl chr 7:100,493,337...100,502,020
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UQCR11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UQCR11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:80,402,997...80,406,821
Ensembl chr10:80,402,997...80,406,830
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases secretion |
ISO |
Aspartame results in increased secretion of VEGFA protein |
CTD |
PMID:20837131 |
|
NCBI chr17:46,016,993...46,032,377
Ensembl chr17:46,016,993...46,032,369
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of XDH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:73,883,895...73,950,397
Ensembl chr17:73,883,895...73,950,196
|
|
|
G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
affects localization |
ISO |
citraconic acid affects the localization of BACH1 protein |
CTD |
PMID:27277809 |
|
NCBI chr16:87,698,954...87,733,346
Ensembl chr16:87,698,945...87,733,346
|
|
G |
Foxm1 |
forkhead box M1 |
increases expression |
ISO |
citraconic acid results in increased expression of FOXM1 protein |
CTD |
PMID:28289076 |
|
NCBI chr 6:128,362,994...128,375,886
Ensembl chr 6:128,362,967...128,376,146
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
increases expression |
ISO |
citraconic acid results in increased expression of FTH1 protein |
CTD |
PMID:28289076 |
|
NCBI chr19:9,980,600...9,985,111
Ensembl chr19:9,980,598...9,985,098
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of FTL protein citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] |
CTD |
PMID:28289076 |
|
NCBI chr 7:45,457,944...45,459,886
Ensembl chr 7:45,457,944...45,459,884
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO EXP |
citraconic acid results in increased expression of GCLC protein citraconic acid results in increased expression of GCLC mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
increases expression |
EXP ISO |
citraconic acid results in increased expression of GCLM mRNA citraconic acid results in increased expression of GCLM protein |
CTD |
PMID:27277809 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Gsr |
glutathione reductase |
increases expression |
ISO EXP |
citraconic acid results in increased expression of GSR protein citraconic acid results in increased expression of GSR mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP ISO |
citraconic acid results in increased expression of HMOX1 mRNA citraconic acid results in increased expression of HMOX1 mRNA; citraconic acid results in increased expression of HMOX1 protein |
CTD |
PMID:27277809 |
|
NCBI chr 8:75,093,618...75,100,593
Ensembl chr 8:75,093,621...75,100,589
|
|
G |
mt-Cytb |
cytochrome b, mitochondrial |
increases expression multiple interactions |
EXP |
citraconic acid results in increased expression of CYTB mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
|
|
G |
mt-Nd1 |
NADH dehydrogenase 1, mitochondrial |
increases expression multiple interactions |
EXP |
citraconic acid results in increased expression of ND1 mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
|
|
G |
mt-Nd5 |
NADH dehydrogenase 5, mitochondrial |
multiple interactions increases expression |
EXP |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
|
|
G |
mt-Nd6 |
NADH dehydrogenase 6, mitochondrial |
multiple interactions increases expression |
EXP |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:13,552...14,070
Ensembl chr MT:13,552...14,070
|
|
G |
Mterf1a |
mitochondrial transcription termination factor 1a |
increases expression |
EXP |
citraconic acid results in increased expression of MTERF1A mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 5:3,864,565...3,893,933
Ensembl chr 5:3,890,581...3,893,933
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization multiple interactions |
ISO EXP |
citraconic acid affects the localization of NFE2L2 protein citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] |
CTD |
PMID:27277809 PMID:28289076 |
|
NCBI chr 2:75,675,513...75,704,663
Ensembl chr 2:75,675,513...75,704,641
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression |
ISO |
citraconic acid results in increased expression of NQO1 mRNA; citraconic acid results in increased expression of NQO1 protein |
CTD |
PMID:27277809 |
|
NCBI chr 8:107,388,225...107,403,205
Ensembl chr 8:107,388,225...107,403,206
|
|
G |
Polrmt |
polymerase (RNA) mitochondrial (DNA directed) |
multiple interactions increases expression |
EXP |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr10:79,736,125...79,746,604
Ensembl chr10:79,736,123...79,746,581
|
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of CASP3 protein |
CTD |
PMID:21105742 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of PARP1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 1:180,568,891...180,600,999
Ensembl chr 1:180,568,924...180,601,254
|
|
G |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of SPTAN1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 2:29,965,560...30,031,451
Ensembl chr 2:29,965,560...30,031,451
|
|
|
G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
affects expression |
EXP |
diethyl malate affects the expression of ACTA2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:34,240,336...34,255,585
Ensembl chr19:34,241,090...34,255,590
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
affects expression |
EXP |
diethyl malate affects the expression of ACTC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:114,047,282...114,052,875
Ensembl chr 2:114,047,282...114,053,548
|
|
G |
Actn3 |
actinin alpha 3 |
affects expression |
EXP |
diethyl malate affects the expression of ACTN3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:4,861,216...4,877,909
Ensembl chr19:4,861,216...4,877,909
|
|
G |
Adcy1 |
adenylate cyclase 1 |
affects expression |
EXP |
diethyl malate affects the expression of ADCY1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:7,063,433...7,178,506
Ensembl chr11:7,063,489...7,178,506
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
affects expression |
EXP |
diethyl malate affects the expression of ADH1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:138,277,585...138,290,698
Ensembl chr 3:138,260,991...138,290,698
|
|
G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
affects expression |
EXP |
diethyl malate affects the expression of AGT mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:124,556,587...124,569,706
Ensembl chr 8:124,556,534...124,569,706
|
|
G |
Aldh1a7 |
aldehyde dehydrogenase family 1, subfamily A7 |
affects expression |
EXP |
diethyl malate affects the expression of ALDH1A7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:20,692,953...20,727,556
Ensembl chr19:20,692,953...20,727,562
|
|
G |
C3 |
complement component 3 |
affects expression |
EXP |
diethyl malate affects the expression of C3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:57,203,967...57,228,136
Ensembl chr17:57,203,970...57,228,136
|
|
G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
affects expression |
EXP |
diethyl malate affects the expression of CACNB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:14,603,861...14,988,811
Ensembl chr 2:14,603,088...14,987,908
|
|
G |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
affects expression |
EXP |
diethyl malate affects the expression of CACNB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:52,428,320...52,676,609
Ensembl chr 2:52,428,320...52,676,831
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions affects expression |
EXP |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CAMK2A mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr18:60,925,307...60,988,152
Ensembl chr18:60,925,618...60,988,152
|
|
G |
Cbr2 |
carbonyl reductase 2 |
affects expression |
EXP |
diethyl malate affects the expression of CBR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:120,729,485...120,732,025
Ensembl chr11:120,729,489...120,732,114
|
|
G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
affects expression |
EXP |
diethyl malate affects the expression of CCL20 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:83,116,766...83,119,167
Ensembl chr 1:83,116,766...83,119,167
|
|
G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
affects expression |
EXP |
diethyl malate affects the expression of CCL6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:83,587,886...83,593,087
Ensembl chr11:83,587,882...83,593,087
|
|
G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
affects expression |
EXP |
diethyl malate affects the expression of CCL7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:82,045,712...82,047,525
Ensembl chr11:82,045,712...82,047,525
|
|
G |
Ccl9 |
chemokine (C-C motif) ligand 9 |
affects expression |
EXP |
diethyl malate affects the expression of CCL9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:83,572,917...83,578,636
Ensembl chr11:83,572,919...83,578,636
|
|
G |
Col11a1 |
collagen, type XI, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of COL11A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:114,030,479...114,220,756
Ensembl chr 3:114,030,540...114,220,718
|
|
G |
Col2a1 |
collagen, type II, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of COL2A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr15:97,975,602...98,004,724
Ensembl chr15:97,975,602...98,004,695
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of COL3A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:45,311,538...45,349,706
Ensembl chr 1:45,311,538...45,349,706
|
|
G |
Col6a1 |
collagen, type VI, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of COL6A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:76,708,792...76,726,044
Ensembl chr10:76,708,792...76,726,168
|
|
G |
Comp |
cartilage oligomeric matrix protein |
affects expression |
EXP |
diethyl malate affects the expression of COMP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:70,373,548...70,382,066
Ensembl chr 8:70,373,558...70,382,066
|
|
G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
affects expression multiple interactions |
EXP |
diethyl malate affects the expression of CXCL12 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CXCL12 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 6:117,168,535...117,181,368
Ensembl chr 6:117,168,535...117,181,367
|
|
G |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
affects expression |
EXP |
diethyl malate affects the expression of CXCL5 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
|
|
G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
affects expression |
EXP |
diethyl malate affects the expression of CXCL1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:90,786,101...90,788,093
Ensembl chr 5:90,786,103...90,789,600
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
affects expression |
EXP |
diethyl malate affects the expression of CYP2J9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:96,568,424...96,592,523
Ensembl chr 4:96,568,429...96,591,578
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
affects expression |
EXP |
diethyl malate affects the expression of DAPK2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:66,158,226...66,272,242
Ensembl chr 9:66,158,223...66,272,242
|
|
G |
Ddx58 |
DEAD/H box helicase 58 |
affects expression |
EXP |
diethyl malate affects the expression of DDX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:40,203,777...40,239,825
Ensembl chr 4:40,203,773...40,239,828
|
|
G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
affects expression |
EXP |
diethyl malate affects the expression of DHRS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:144,892,534...144,928,209
Ensembl chr 4:144,892,827...144,928,209
|
|
G |
Dhx58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
affects expression |
EXP |
diethyl malate affects the expression of DHX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:100,694,884...100,704,271
Ensembl chr11:100,694,884...100,704,271
|
|
G |
Edar |
ectodysplasin-A receptor |
affects expression |
EXP |
diethyl malate affects the expression of EDAR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:58,600,780...58,675,696
Ensembl chr10:58,600,789...58,675,654
|
|
G |
Ednra |
endothelin receptor type A |
affects expression |
EXP |
diethyl malate affects the expression of EDNRA mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:77,663,029...77,724,452
Ensembl chr 8:77,663,031...77,724,464
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
affects expression |
EXP |
diethyl malate affects the expression of EPAS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:86,753,864...86,833,410
Ensembl chr17:86,753,700...86,833,410
|
|
G |
Epha7 |
Eph receptor A7 |
affects expression |
EXP |
diethyl malate affects the expression of EPHA7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:28,813,066...28,967,503
Ensembl chr 4:28,813,131...28,967,499
|
|
G |
Ephb2 |
Eph receptor B2 |
affects expression |
EXP |
diethyl malate affects the expression of EPHB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:136,647,536...136,836,326
Ensembl chr 4:136,647,539...136,835,988
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
EXP |
diethyl malate affects the expression of EPHB6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:41,603,834...41,620,509
Ensembl chr 6:41,605,482...41,620,509
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects expression |
EXP |
diethyl malate affects the expression of FGF10 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr13:118,714,699...118,792,573
Ensembl chr13:118,669,791...118,792,115
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
multiple interactions affects expression |
EXP |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of FGF18 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr11:33,116,970...33,147,400
Ensembl chr11:33,117,430...33,147,400
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
EXP |
diethyl malate affects the expression of FGFR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:130,162,451...130,266,808
Ensembl chr 7:130,162,451...133,123,350
|
|
G |
Fst |
follistatin |
affects expression |
EXP |
diethyl malate affects the expression of FST mRNA |
CTD |
PMID:24814887 |
|
NCBI chr13:114,452,262...114,458,989
Ensembl chr13:114,452,290...114,458,951
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects expression |
EXP |
diethyl malate affects the expression of FZD2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:102,604,431...102,608,058
Ensembl chr11:102,604,396...102,608,058
|
|
G |
Fzd7 |
frizzled class receptor 7 |
affects expression |
EXP |
diethyl malate affects the expression of FZD7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:59,482,147...59,486,955
Ensembl chr 1:59,482,424...59,486,955
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
EXP |
diethyl malate affects the expression of GCLC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
multiple interactions affects expression |
EXP |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Ggt6 |
gamma-glutamyltransferase 6 |
affects expression |
EXP |
diethyl malate affects the expression of GGT6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:72,435,247...72,438,566
Ensembl chr11:72,435,526...72,438,400
|
|
G |
Gli2 |
GLI-Kruppel family member GLI2 |
affects expression |
EXP |
diethyl malate affects the expression of GLI2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:118,834,061...119,054,405
Ensembl chr 1:118,834,132...119,053,619
|
|
G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
affects expression |
EXP |
diethyl malate affects the expression of GNAO1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:93,810,153...93,969,388
Ensembl chr 8:93,809,966...93,969,388
|
|
G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
affects expression |
EXP |
diethyl malate affects the expression of GNG7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:80,948,624...81,014,925
Ensembl chr10:80,948,624...81,014,945
|
|
G |
Gsr |
glutathione reductase |
affects expression |
EXP |
diethyl malate affects the expression of GSR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
|
|
G |
Gss |
glutathione synthetase |
multiple interactions affects expression |
EXP |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSS mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 2:155,563,181...155,592,810
Ensembl chr 2:155,563,181...155,592,810
|
|
G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
affects expression multiple interactions |
EXP |
diethyl malate affects the expression of GSTA1 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA1 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 9:78,331,018...78,347,192
Ensembl chr 9:78,331,018...78,355,788
|
|
G |
Gsta3 |
glutathione S-transferase, alpha 3 |
affects expression multiple interactions |
EXP |
diethyl malate affects the expression of GSTA3 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA3 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 1:21,240,565...21,265,575
Ensembl chr 1:21,240,589...21,265,661
|
|
G |
Gucy1a1 |
guanylate cyclase 1, soluble, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of GUCY1A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:82,092,427...82,145,946
Ensembl chr 3:82,092,427...82,145,789
|
|
G |
Gucy1b1 |
guanylate cyclase 1, soluble, beta 1 |
affects expression |
EXP |
diethyl malate affects the expression of GUCY1B1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:82,032,004...82,074,711
Ensembl chr 3:82,032,006...82,074,689
|
|
G |
H2-DMb1 |
histocompatibility 2, class II, locus Mb1 |
affects expression |
EXP |
diethyl malate affects the expression of H2-DMB1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:34,153,191...34,160,229
Ensembl chr17:34,153,072...34,160,230
|
|
G |
H2-M3 |
histocompatibility 2, M region locus 3 |
affects expression |
EXP |
diethyl malate affects the expression of H2-M3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:37,270,234...37,274,485
Ensembl chr17:37,270,220...37,274,484
|
|
G |
Hck |
hemopoietic cell kinase |
affects expression |
EXP |
diethyl malate affects the expression of HCK mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:153,108,468...153,151,441
Ensembl chr 2:153,108,468...153,151,441
|
|
G |
Hgf |
hepatocyte growth factor |
affects expression |
EXP |
diethyl malate affects the expression of HGF mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:16,553,495...16,619,439
Ensembl chr 5:16,553,495...16,620,152
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
EXP |
diethyl malate affects the expression of IGF1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:87,858,265...87,937,047
Ensembl chr10:87,858,265...87,937,042
|
|
G |
Il15 |
interleukin 15 |
affects expression |
EXP |
diethyl malate affects the expression of IL15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:82,331,624...82,403,252
Ensembl chr 8:82,331,632...82,403,222
|
|
G |
Il18 |
interleukin 18 |
affects expression |
EXP |
diethyl malate affects the expression of IL18 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:50,554,700...50,581,841
Ensembl chr 9:50,554,827...50,581,840
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
affects expression |
EXP |
diethyl malate affects the expression of IRAG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:110,868,257...110,982,909
Ensembl chr 7:110,868,266...110,982,461
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects expression |
EXP |
diethyl malate affects the expression of IRF7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:141,263,183...141,266,499
Ensembl chr 7:141,262,706...141,266,481
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects expression |
EXP |
diethyl malate affects the expression of ISG15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:156,199,424...156,200,818
Ensembl chr 4:156,199,455...156,200,796
|
|
G |
Itga11 |
integrin alpha 11 |
affects expression |
EXP |
diethyl malate affects the expression of ITGA11 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:62,677,855...62,783,979
Ensembl chr 9:62,677,826...62,783,982
|
|
G |
Itga3 |
integrin alpha 3 |
affects expression |
EXP |
diethyl malate affects the expression of ITGA3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:95,044,475...95,076,844
Ensembl chr11:95,044,474...95,076,801
|
|
G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
affects expression |
EXP |
diethyl malate affects the expression of KCNMB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:116,417,861...116,473,859
Ensembl chr10:116,417,861...116,473,878
|
|
G |
Lama1 |
laminin, alpha 1 |
affects expression |
EXP |
diethyl malate affects the expression of LAMA1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:67,697,127...67,822,645
Ensembl chr17:67,697,259...67,822,647
|
|
G |
Lama4 |
laminin, alpha 4 |
affects expression |
EXP |
diethyl malate affects the expression of LAMA4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:38,965,515...39,110,188
Ensembl chr10:38,965,515...39,110,188
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
affects phosphorylation multiple interactions |
EXP |
diethyl malate affects the phosphorylation of MAPK1 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:24814887 |
|
NCBI chr16:16,983,382...17,047,453
Ensembl chr16:16,983,382...17,047,453
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
affects phosphorylation multiple interactions |
EXP |
diethyl malate affects the phosphorylation of MAPK3 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:24814887 |
|
NCBI chr 7:126,759,626...126,765,816
Ensembl chr 7:126,759,601...126,765,819
|
|
G |
Myl9 |
myosin, light polypeptide 9, regulatory |
affects expression |
EXP |
diethyl malate affects the expression of MYL9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:156,775,408...156,781,657
Ensembl chr 2:156,775,420...156,781,658
|
|
G |
Odc1 |
ornithine decarboxylase, structural 1 |
affects expression |
EXP |
diethyl malate affects the expression of ODC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr12:17,544,808...17,551,502
Ensembl chr12:17,544,794...17,551,505
|
|
G |
Pdgfb |
platelet derived growth factor, B polypeptide |
affects expression multiple interactions |
EXP |
diethyl malate affects the expression of PDGFB mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of PDGFB mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr15:79,995,865...80,024,614
Ensembl chr15:79,995,874...80,014,977
|
|
G |
Pdgfd |
platelet-derived growth factor, D polypeptide |
affects expression |
EXP |
diethyl malate affects the expression of PDGFD mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:6,168,363...6,534,284
Ensembl chr 9:6,168,584...6,378,850
|
|
G |
Pf4 |
platelet factor 4 |
affects expression |
EXP |
diethyl malate affects the expression of PF4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:90,772,435...90,773,383
Ensembl chr 5:90,772,435...90,773,383
|
|
G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
affects expression |
EXP |
diethyl malate affects the expression of PIK3IP1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:3,319,241...3,342,971
Ensembl chr11:3,330,401...3,342,971
|
|
G |
Plxnc1 |
plexin C1 |
affects expression |
EXP |
diethyl malate affects the expression of PLXNC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:94,790,866...94,945,015
Ensembl chr10:94,790,866...94,944,835
|
|
G |
Prkg1 |
protein kinase, cGMP-dependent, type I |
affects expression |
EXP |
diethyl malate affects the expression of PRKG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:30,564,487...31,765,268
Ensembl chr19:30,564,489...31,765,033
|
|
G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
affects expression |
EXP |
diethyl malate affects the expression of PTGIS mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:167,203,194...167,252,150
Ensembl chr 2:167,191,805...167,240,604
|
|
G |
Ramp2 |
receptor (calcitonin) activity modifying protein 2 |
affects expression |
EXP |
diethyl malate affects the expression of RAMP2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr11:101,246,334...101,248,250
Ensembl chr11:101,246,028...101,259,546
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
affects expression |
EXP |
diethyl malate affects the expression of RGS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:62,559,835...62,703,019
Ensembl chr 4:62,559,847...62,704,001
|
|
G |
Runx1t1 |
RUNX1 translocation partner 1 |
affects expression |
EXP |
diethyl malate affects the expression of RUNX1T1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:13,742,628...13,895,056
Ensembl chr 4:13,743,436...13,893,649
|
|
G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
affects expression |
EXP |
diethyl malate affects the expression of SEMA3B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:107,597,674...107,609,241
Ensembl chr 9:107,597,674...107,609,229
|
|
G |
Sema4g |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
affects expression |
EXP |
diethyl malate affects the expression of SEMA4G mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:44,988,743...45,003,397
Ensembl chr19:44,989,101...45,003,397
|
|
G |
Sema5a |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
affects expression |
EXP |
diethyl malate affects the expression of SEMA5A mRNA |
CTD |
PMID:24814887 |
|
NCBI chr15:32,244,813...32,696,341
Ensembl chr15:32,244,810...32,696,341
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
affects expression |
EXP |
diethyl malate affects the expression of STAT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:52,119,438...52,161,865
Ensembl chr 1:52,119,440...52,161,865
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
affects expression multiple interactions |
EXP |
diethyl malate affects the expression of TGFB2 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of TGFB2 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 1:186,622,787...186,709,697
Ensembl chr 1:186,622,792...186,705,989
|
|
G |
Thbs1 |
thrombospondin 1 |
affects expression |
EXP |
diethyl malate affects the expression of THBS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:118,111,876...118,127,133
Ensembl chr 2:118,111,876...118,127,133
|
|
G |
Thbs2 |
thrombospondin 2 |
affects expression |
EXP |
diethyl malate affects the expression of THBS2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:14,665,500...14,694,262
Ensembl chr17:14,665,500...14,694,235
|
|
G |
Tnc |
tenascin C |
affects expression |
EXP |
diethyl malate affects the expression of TNC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:63,959,785...64,047,015
Ensembl chr 4:63,959,785...64,047,015
|
|
G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
affects expression |
EXP |
diethyl malate affects the expression of TNFRSF11B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr15:54,250,619...54,278,484
Ensembl chr15:54,250,619...54,278,484
|
|
G |
Tnnt1 |
troponin T1, skeletal, slow |
affects expression |
EXP |
diethyl malate affects the expression of TNNT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:4,504,569...4,515,975
Ensembl chr 7:4,504,570...4,516,382
|
|
G |
Tslp |
thymic stromal lymphopoietin |
affects expression |
EXP |
diethyl malate affects the expression of TSLP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr18:32,815,383...32,819,799
Ensembl chr18:32,815,383...32,819,797
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of ABCC2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:43,782,308...43,838,332
Ensembl chr19:43,782,192...43,840,740
|
|
G |
Abhd4 |
abhydrolase domain containing 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of ABHD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:54,254,129...54,269,169
Ensembl chr14:54,254,188...54,270,637
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ACACA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:84,129,635...84,401,651
Ensembl chr11:84,129,672...84,401,651
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]; resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]] |
CTD |
PMID:17134953 |
|
NCBI chr11:116,171,883...116,199,045
Ensembl chr11:116,171,888...116,199,045
|
|
G |
Acy3 |
aspartoacylase (aminoacylase) 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ACY3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:3,986,570...3,990,007
Ensembl chr19:3,986,570...3,990,007
|
|
G |
Adora3 |
adenosine A3 receptor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ADORA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:105,904,421...105,908,928
Ensembl chr 3:105,870,858...105,908,926
|
|
G |
Afp |
alpha fetoprotein |
increases expression |
EXP |
diethyl maleate results in increased expression of AFP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:90,490,714...90,508,907
Ensembl chr 5:90,490,737...90,508,907
|
|
G |
Ahcyl1 |
S-adenosylhomocysteine hydrolase-like 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of AHCYL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:107,663,120...107,696,560
Ensembl chr 3:107,663,118...107,696,560
|
|
G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
increases expression |
ISO |
diethyl maleate results in increased expression of AKR1A1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 4:116,636,510...116,651,674
Ensembl chr 4:116,636,510...116,651,680
|
|
G |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
increases expression |
EXP |
diethyl maleate results in increased expression of AKR1C19 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:4,233,503...4,248,361
Ensembl chr13:4,228,700...4,252,843
|
|
G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
increases expression |
ISO |
diethyl maleate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr13:4,574,075...4,586,543
Ensembl chr13:4,574,075...4,586,541
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
affects reduction |
EXP |
diethyl maleate affects the reduction of ALDH1A1 protein |
CTD |
PMID:19843705 |
|
NCBI chr19:20,492,583...20,643,463
Ensembl chr19:20,492,715...20,643,465
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
decreases reduction increases expression decreases expression |
EXP ISO |
diethyl maleate results in decreased reduction of ALDH2 protein diethyl maleate results in increased expression of ALDH2 protein diethyl maleate results in decreased expression of ALDH2 protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr 5:121,566,027...121,593,824
Ensembl chr 5:121,566,027...121,593,824
|
|
G |
Aldob |
aldolase B, fructose-bisphosphate |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ALDOB protein |
CTD |
PMID:21161181 |
|
NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:97,244,074...97,247,287
Ensembl chr15:97,244,125...97,247,287
|
|
G |
Angptl2 |
angiopoietin-like 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:33,215,951...33,247,725
Ensembl chr 2:33,216,069...33,247,717
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ANKRD46 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:36,477,668...36,496,791
Ensembl chr15:36,477,668...36,496,820
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
diethyl maleate results in increased expression of ANLN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:22,331,214...22,389,211
Ensembl chr 9:22,332,012...22,389,188
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ANXA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:96,793,385...96,845,968
Ensembl chr 5:96,793,339...96,845,966
|
|
G |
Ap3m2 |
adaptor-related protein complex 3, mu 2 subunit |
decreases expression |
ISO |
diethyl maleate results in decreased expression of AP3M2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:22,787,354...22,807,292
Ensembl chr 8:22,787,354...22,805,622
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of APAF1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr10:90,989,311...91,082,743
Ensembl chr10:90,989,311...91,082,770
|
|
G |
Aplp1 |
amyloid beta (A4) precursor-like protein 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of APLP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:30,434,980...30,445,582
Ensembl chr 7:30,434,982...30,445,535
|
|
G |
Apol6 |
apolipoprotein L 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of APOL9A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:77,045,050...77,057,108
Ensembl chr15:77,044,729...77,057,106
|
|
G |
Apol9a |
apolipoprotein L 9a |
decreases expression |
ISO |
diethyl maleate results in decreased expression of APOL9A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:77,403,789...77,411,080
Ensembl chr15:77,403,789...77,411,135
|
|
G |
Arrdc2 |
arrestin domain containing 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ARRDC2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:70,835,129...70,839,720
Ensembl chr 8:70,835,129...70,839,720
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ARRDC4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:68,736,994...68,749,238
Ensembl chr 7:68,736,995...68,749,241
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
ISO |
diethyl maleate results in increased expression of ASF1B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:83,955,694...83,970,195
Ensembl chr 8:83,955,507...83,970,197
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ASXL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:153,345,830...153,404,007
Ensembl chr 2:153,345,829...153,404,007
|
|
G |
Atm |
ataxia telangiectasia mutated |
increases expression |
ISO |
diethyl maleate results in increased expression of ATM mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 9:53,437,122...53,536,828
Ensembl chr 9:53,439,149...53,536,740
|
|
G |
Atp5b |
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
increases expression |
ISO |
diethyl maleate results in increased expression of ATP5F1B protein |
CTD |
PMID:21161181 |
|
NCBI chr10:128,083,307...128,090,388
Ensembl chr10:128,083,273...128,090,391
|
|
G |
Aurka |
aurora kinase A |
increases expression decreases expression |
ISO EXP |
diethyl maleate results in increased expression of AURKA mRNA diethyl maleate results in decreased expression of AURKA mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 2:172,356,190...172,370,886
Ensembl chr 2:172,356,190...172,370,535
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
EXP |
[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
|
|
G |
Bcl2a1b |
B cell leukemia/lymphoma 2 related protein A1b |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BCL2A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:89,199,273...89,207,838
Ensembl chr 9:89,199,209...89,207,827
|
|
G |
Bcl3 |
B cell leukemia/lymphoma 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BCL3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:19,808,462...19,822,824
Ensembl chr 7:19,808,462...19,822,770
|
|
G |
Bcl6b |
B cell CLL/lymphoma 6, member B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BCL6B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:70,224,127...70,229,798
Ensembl chr11:70,224,128...70,229,798
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BHLHE41 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:145,858,243...145,865,420
Ensembl chr 6:145,858,243...145,865,558
|
|
G |
Bhmt |
betaine-homocysteine methyltransferase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BHMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:93,616,891...93,637,758
Ensembl chr13:93,616,675...93,637,961
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
EXP |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA] |
CTD |
PMID:12774022 |
|
NCBI chr 9:7,847,468...7,873,205
Ensembl chr 9:7,848,699...7,873,186
|
|
G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
increases expression |
EXP |
diethyl maleate results in increased expression of BLVRB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:27,447,978...27,465,981
Ensembl chr 7:27,447,978...27,466,144
|
|
G |
Bmf |
BCL2 modifying factor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BMF mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:118,528,757...118,549,686
Ensembl chr 2:118,528,757...118,549,687
|
|
G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of BRIP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:86,058,136...86,201,215
Ensembl chr11:86,058,138...86,201,193
|
|
G |
Btbd2 |
BTB (POZ) domain containing 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BTBD2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:80,642,623...80,656,494
Ensembl chr10:80,642,617...80,657,071
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression decreases expression multiple interactions |
EXP |
diethyl maleate results in increased expression of BTG2 mRNA diethyl maleate results in decreased expression of BTG2 mRNA NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] |
CTD |
PMID:22003191 PMID:25270620 |
|
NCBI chr 1:134,074,865...134,079,155
Ensembl chr 1:134,075,170...134,079,120
|
|
G |
C6 |
complement component 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of C6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:4,727,067...4,804,045
Ensembl chr15:4,727,175...4,814,967
|
|
G |
Casp2 |
caspase 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP2 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 6:42,264,902...42,282,508
Ensembl chr 6:42,264,985...42,282,508
|
|
G |
Casp3 |
caspase 3 |
increases expression increases cleavage |
ISO |
diethyl maleate results in increased expression of CASP3 mRNA diethyl maleate results in increased cleavage of CASP3 protein |
CTD |
PMID:11875189 PMID:21105742 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP9 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
|
|
G |
Cat |
catalase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CAT protein |
CTD |
PMID:21161181 |
|
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of CBR1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:93,607,837...93,610,349
Ensembl chr16:93,605,853...93,610,505
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression multiple interactions |
ISO EXP |
diethyl maleate results in increased expression of CBR3 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diethyl maleate results in increased expression of CBR3 mRNA] |
CTD |
PMID:20806931 PMID:25270620 |
|
NCBI chr16:93,683,219...93,690,991
Ensembl chr16:93,683,215...93,690,990
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CCDC50 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:27,387,065...27,452,218
Ensembl chr16:27,388,869...27,452,218
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNA1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 3:55,045,469...55,057,634
Ensembl chr 3:55,045,469...55,055,501
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CCNA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:36,564,865...36,573,038
Ensembl chr 3:36,564,865...36,572,150
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression increases expression |
ISO EXP |
diethyl maleate results in decreased expression of CCND1 mRNA diethyl maleate results in increased expression of CCND1 mRNA |
CTD |
PMID:11875189 PMID:21161181 PMID:25270620 |
|
NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CCNE2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:11,190,433...11,204,779
Ensembl chr 4:11,191,351...11,204,779
|
|
G |
Ccnk |
cyclin K |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNK mRNA |
CTD |
PMID:11875189 |
|
NCBI chr12:108,179,308...108,203,359
Ensembl chr12:108,179,579...108,203,359
|
|
G |
Cd80 |
CD80 antigen |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein diethyl maleate results in increased expression of CD80 protein |
CTD |
PMID:31958493 |
|
NCBI chr16:38,457,430...38,495,958
Ensembl chr16:38,455,561...38,496,335
|
|
G |
Cd86 |
CD86 antigen |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; bisindolylmaleimide I inhibits the reaction [diethyl maleate results in increased expression of CD86 protein] |
CTD |
PMID:24136171 PMID:31958493 |
|
NCBI chr16:36,568,956...36,666,158
Ensembl chr16:36,603,869...36,666,081
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
ISO |
diethyl maleate results in increased expression of CDC25A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:109,875,518...109,893,895
Ensembl chr 9:109,875,579...109,893,895
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CDCA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:67,673,180...67,715,841
Ensembl chr14:67,676,331...67,715,841
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of CDCA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:124,829,530...124,833,701
Ensembl chr 6:124,829,547...124,833,701
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
ISO |
diethyl maleate results in increased expression of CDCA8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:124,918,465...124,936,917
Ensembl chr 4:124,918,465...124,939,311
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CDH11 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:102,632,095...102,785,493
Ensembl chr 8:102,632,095...102,785,642
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of CDKN1A mRNA; diethyl maleate results in increased expression of CDKN1A protein TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein] |
CTD |
PMID:11875189 PMID:27982581 |
|
NCBI chr17:29,090,979...29,100,722
Ensembl chr17:29,090,976...29,100,727
|
|
G |
Cds2 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDS2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:132,253,338...132,312,050
Ensembl chr 2:132,263,148...132,312,050
|
|
G |
Ces1d |
carboxylesterase 1D |
increases reduction decreases expression |
EXP ISO |
diethyl maleate results in increased reduction of CES1D protein diethyl maleate results in decreased expression of CES1D protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr 8:93,166,072...93,197,804
Ensembl chr 8:93,166,068...93,197,838
|
|
G |
Ces2a |
carboxylesterase 2A |
increases reduction |
EXP |
diethyl maleate results in increased reduction of CES2A protein |
CTD |
PMID:19843705 |
|
NCBI chr 8:104,734,003...104,741,634
Ensembl chr 8:104,734,003...104,741,634
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CFLAR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:58,711,311...58,758,884
Ensembl chr 1:58,711,508...58,758,884
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CIDEC mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:113,424,634...113,435,760
Ensembl chr 6:113,424,634...113,435,760
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CITED2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:17,723,228...17,725,674
Ensembl chr10:17,723,218...17,725,674
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CITED4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:120,666,563...120,667,820
Ensembl chr 4:120,666,572...120,667,820
|
|
G |
Ckb |
creatine kinase, brain |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of CKB protein |
CTD |
PMID:19843705 |
|
NCBI chr12:111,669,355...111,672,338
Ensembl chr12:111,669,361...111,672,338
|
|
G |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CMPK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:26,469,117...26,479,837
Ensembl chr12:26,469,204...26,479,837
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of COL1A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:94,936,224...94,953,042
Ensembl chr11:94,936,224...94,953,042
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:45,311,538...45,349,706
Ensembl chr 1:45,311,538...45,349,706
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of COMMD3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:18,672,435...18,676,231
Ensembl chr 2:18,672,384...18,676,231
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of COMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:18,406,882...18,426,716
Ensembl chr16:18,406,886...18,426,852
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:19,956,933...20,009,750
Ensembl chr 3:19,957,054...20,009,145
|
|
G |
Crym |
crystallin, mu |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CRYM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:120,186,380...120,201,989
Ensembl chr 7:120,186,380...120,202,111
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:135,720,063...135,752,229
Ensembl chr 1:135,720,061...135,752,232
|
|
G |
Csrp3 |
cysteine and glycine-rich protein 3 |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of CSRP3 protein |
CTD |
PMID:19843705 |
|
NCBI chr 7:48,830,398...48,848,051
Ensembl chr 7:48,830,398...48,848,033
|
|
G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CXCL10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:92,346,638...92,348,889
Ensembl chr 5:92,346,638...92,348,889
|
|
G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CXCL12 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:117,168,535...117,181,368
Ensembl chr 6:117,168,535...117,181,367
|
|
G |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
increases expression multiple interactions increases secretion increases stability |
ISO |
diethyl maleate results in increased expression of CXCL8 mRNA; diethyl maleate results in increased expression of CXCL8 protein bisindolylmaleimide I inhibits the reaction [diethyl maleate results in increased expression of CXCL8 protein] diethyl maleate results in increased secretion of CXCL8 protein diethyl maleate results in increased stability of CXCL8 mRNA |
CTD |
PMID:20491607 PMID:20541004 PMID:21920952 PMID:21969073 PMID:24136171 PMID:31958493 |
|
NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
|
|
G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CXCL9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:92,321,331...92,328,079
Ensembl chr 5:92,321,347...92,328,079
|
|
G |
Cyb5a |
cytochrome b5 type A (microsomal) |
increases expression |
EXP |
diethyl maleate results in increased expression of CYB5A mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:84,851,338...84,879,871
Ensembl chr18:84,838,704...84,879,871
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:84,571,414...84,593,908
Ensembl chr 6:84,571,414...84,593,908
|
|
G |
D17H6S56E-5 |
DNA segment, Chr 17, human D6S56E 5 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of D17H6S56E-5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:34,996,678...35,000,774
|
|
G |
Dbp |
D site albumin promoter binding protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:45,705,100...45,710,203
Ensembl chr 7:45,705,088...45,710,203
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
EXP |
diethyl maleate results in increased expression of DDIT4L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:137,623,672...137,628,332
Ensembl chr 3:137,621,612...137,628,333
|
|
G |
Dhx58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DHX58 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:100,694,884...100,704,271
Ensembl chr11:100,694,884...100,704,271
|
|
G |
Dnmbp |
dynamin binding protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DNMBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:43,846,815...43,940,232
Ensembl chr19:43,846,821...43,940,191
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of DPYSL2 protein |
CTD |
PMID:19843705 |
|
NCBI chr14:66,802,864...66,911,041
Ensembl chr14:66,802,864...66,868,688
|
|
G |
Dtx3l |
deltex 3-like, E3 ubiquitin ligase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DTX3L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:35,926,515...35,939,027
Ensembl chr16:35,926,511...35,939,151
|
|
G |
Dus3l |
dihydrouridine synthase 3-like (S. cerevisiae) |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DUS3L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:56,764,751...56,770,093
Ensembl chr17:56,764,757...56,770,093
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of EEF2K mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:120,842,642...120,907,219
Ensembl chr 7:120,842,831...120,907,450
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:78,850,504...78,882,572
Ensembl chr17:78,852,564...78,882,573
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
EXP |
diethyl maleate results in increased expression of ENTPD5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:84,373,875...84,409,029
Ensembl chr12:84,373,857...84,409,029
|
|
G |
Eras |
ES cell-expressed Ras |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ERAS mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:7,924,276...7,928,607
Ensembl chr X:7,924,276...7,928,607
|
|
G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 like |
increases expression |
ISO |
diethyl maleate results in increased expression of ERCC6L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:102,142,820...102,157,091
Ensembl chr X:102,141,716...102,157,091
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of EXO1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:175,880,768...175,911,396
Ensembl chr 1:175,880,581...175,913,489
|
|
G |
Fabp1 |
fatty acid binding protein 1, liver |
increases expression |
ISO |
diethyl maleate results in increased expression of FABP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 6:71,199,879...71,205,034
Ensembl chr 6:71,199,827...71,205,023
|
|
G |
Fabp7 |
fatty acid binding protein 7, brain |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FABP7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:57,784,923...57,788,450
Ensembl chr10:57,784,881...57,788,450
|
|
G |
Fam126b |
family with sequence similarity 126, member B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FAM126B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:58,522,806...58,586,333
Ensembl chr 1:58,522,806...58,586,323
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FASN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:120,805,958...120,825,166
Ensembl chr11:120,805,846...120,824,547
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FBN1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:125,300,594...125,506,485
Ensembl chr 2:125,300,594...125,507,993
|
|
G |
Fbp1 |
fructose bisphosphatase 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FBP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr13:62,864,753...62,888,298
Ensembl chr13:62,864,753...62,888,282
|
|
G |
Fgf17 |
fibroblast growth factor 17 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FGF17 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:70,636,203...70,642,268
Ensembl chr14:70,636,203...70,642,268
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FGG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:83,007,724...83,015,056
Ensembl chr 3:83,007,724...83,015,049
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FGR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:132,974,095...133,001,893
Ensembl chr 4:132,974,095...133,001,910
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FNDC3B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:27,416,135...27,711,307
Ensembl chr 3:27,416,162...27,711,307
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression |
EXP |
diethyl maleate results in increased expression of FOS mRNA |
CTD |
PMID:10915739 |
|
NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
|
|
G |
G6pc |
glucose-6-phosphatase, catalytic |
decreases expression |
EXP |
diethyl maleate results in decreased expression of G6PC mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:101,367,716...101,377,903
Ensembl chr11:101,367,561...101,377,903
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
increases activity |
ISO |
diethyl maleate results in increased activity of G6PD protein |
CTD |
PMID:3099627 |
|
NCBI chr X:74,409,483...74,428,880
Ensembl chr X:74,409,483...74,429,194
|
|
G |
Gab1 |
growth factor receptor bound protein 2-associated protein 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GAB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:80,764,431...80,880,519
Ensembl chr 8:80,764,438...80,880,519
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases reduction |
EXP |
diethyl maleate results in increased reduction of GAPDH protein |
CTD |
PMID:19843705 |
|
NCBI chr 6:125,161,852...125,166,467
Ensembl chr 6:125,161,715...125,166,467
|
|
G |
Gba2 |
glucosidase beta 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GBA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:43,566,928...43,578,886
Ensembl chr 4:43,566,928...43,578,873
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GBP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:142,620,663...142,638,008
Ensembl chr 3:142,620,602...142,638,008
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity increases expression |
EXP ISO |
diethyl maleate results in increased activity of GCLC protein diethyl maleate results in increased expression of GCLC mRNA; diethyl maleate results in increased expression of GCLC protein |
CTD |
PMID:10915739 PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
increases expression |
ISO EXP |
diethyl maleate results in increased expression of GCLM mRNA; diethyl maleate results in increased expression of GCLM protein |
CTD |
PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Glul |
glutamate-ammonia ligase (glutamine synthetase) |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GLUL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:153,899,929...153,909,723
Ensembl chr 1:153,899,944...153,909,723
|
|
G |
Got2 |
glutamatic-oxaloacetic transaminase 2, mitochondrial |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GOT2 protein |
CTD |
PMID:21161181 |
|
NCBI chr 8:95,864,133...95,888,401
Ensembl chr 8:95,864,134...95,888,547
|
|
G |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GPIHBP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:75,596,630...75,598,213
Ensembl chr15:75,596,628...75,599,481
|
|
G |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GRIA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:41,400,819...41,678,601
Ensembl chr X:41,400,854...41,678,601
|
|
G |
Gsn |
gelsolin |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of GSN protein |
CTD |
PMID:19843705 |
|
NCBI chr 2:35,256,359...35,307,902
Ensembl chr 2:35,256,380...35,307,892
|
|
G |
Gsr |
glutathione reductase |
increases expression |
EXP |
diethyl maleate results in increased expression of GSR mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:33,653,238...33,698,162
Ensembl chr 8:33,652,523...33,698,163
|
|
G |
Gss |
glutathione synthetase |
increases expression |
ISO |
diethyl maleate results in increased expression of GSS mRNA |
CTD |
PMID:10978506 |
|
NCBI chr 2:155,563,181...155,592,810
Ensembl chr 2:155,563,181...155,592,810
|
|
G |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTA5 protein |
CTD |
PMID:9794803 |
|
NCBI chr 9:78,230,669...78,242,683
Ensembl chr 9:78,230,656...78,242,684
|
|
G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTA3 protein |
CTD |
PMID:9794803 |
|
NCBI chr 9:78,331,018...78,347,192
Ensembl chr 9:78,331,018...78,355,788
|
|
G |
Gsta3 |
glutathione S-transferase, alpha 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:21,240,565...21,265,575
Ensembl chr 1:21,240,589...21,265,661
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
EXP |
[diethyl maleate results in decreased abundance of Glutathione] which results in decreased expression of GSTK1 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 6:42,245,935...42,250,441
Ensembl chr 6:42,245,935...42,250,447
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GSTM1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 3:108,012,250...108,017,973
Ensembl chr 3:108,012,255...108,017,973
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTO1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:47,854,973...47,864,790
Ensembl chr19:47,854,970...47,864,790
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTP1 protein |
CTD |
PMID:9794803 |
|
NCBI chr19:4,035,411...4,037,912
Ensembl chr19:4,035,407...4,037,985
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTT1 protein |
CTD |
PMID:9794803 |
|
NCBI chr10:75,783,813...75,798,584
Ensembl chr10:75,783,813...75,798,584
|
|
G |
Gtse1 |
G two S phase expressed protein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GTSE1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:85,859,691...85,876,573
Ensembl chr15:85,859,745...85,876,573
|
|
G |
H2-T23 |
histocompatibility 2, T region locus 23 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of RT1-S3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:36,029,977...36,032,701
Ensembl chr17:36,029,773...36,032,855
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression |
EXP |
diethyl maleate results in increased expression of H6PD mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:149,979,474...150,009,023
Ensembl chr 4:149,979,475...150,009,023
|
|
G |
Helb |
helicase (DNA) B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HELB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:120,083,608...120,113,010
Ensembl chr10:120,083,608...120,112,987
|
|
G |
Hes6 |
hairy and enhancer of split 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of HES6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:91,411,483...91,414,038
Ensembl chr 1:91,411,483...91,414,038
|
|
G |
Hjurp |
Holliday junction recognition protein |
increases expression |
ISO |
diethyl maleate results in increased expression of HJURP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:88,258,856...88,277,644
Ensembl chr 1:88,262,471...88,277,633
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO EXP |
diethyl maleate results in increased expression of HMOX1 mRNA |
CTD |
PMID:20491607 PMID:25270620 |
|
NCBI chr 8:75,093,618...75,100,593
Ensembl chr 8:75,093,621...75,100,589
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of HNRNPH1 protein |
CTD |
PMID:19843705 |
|
NCBI chr11:50,375,257...50,386,528
Ensembl chr11:50,376,990...50,386,528
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:117,700,982...117,759,030
Ensembl chr 8:117,701,904...117,759,027
|
|
G |
Hspa5 |
heat shock protein 5 |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of HSPA5 protein |
CTD |
PMID:19843705 |
|
NCBI chr 2:34,772,090...34,776,529
Ensembl chr 2:34,771,970...34,777,547
|
|
G |
Hspa8 |
heat shock protein 8 |
increases reduction |
EXP |
diethyl maleate results in increased reduction of HSPA8 protein |
CTD |
PMID:19843705 |
|
NCBI chr 9:40,801,276...40,805,202
Ensembl chr 9:40,800,984...40,810,087
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of HTATIP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:49,759,045...49,774,000
Ensembl chr 7:49,759,115...49,773,975
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ICAM1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ID3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:136,143,822...136,145,392
Ensembl chr 4:136,143,497...136,145,755
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ID4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:48,261,116...48,266,028
Ensembl chr13:48,261,228...48,266,026
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IFIT3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:34,583,119...34,588,982
Ensembl chr19:34,583,531...34,588,731
|
|
G |
Ikbke |
inhibitor of kappaB kinase epsilon |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IKBKE mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:131,254,600...131,279,601
Ensembl chr 1:131,254,343...131,279,606
|
|
G |
Ikbkg |
inhibitor of kappaB kinase gamma |
increases expression |
EXP |
diethyl maleate results in increased expression of IKBKG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:74,393,233...74,456,792
Ensembl chr X:74,393,290...74,453,854
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
diethyl maleate results in increased secretion of IL10 protein |
CTD |
PMID:31958493 |
|
NCBI chr 1:131,019,845...131,024,970
Ensembl chr 1:131,019,845...131,024,974
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
diethyl maleate results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 9:50,554,700...50,581,841
Ensembl chr 9:50,554,827...50,581,840
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 protein] |
CTD |
PMID:7476933 |
|
NCBI chr 2:129,299,609...129,310,186
Ensembl chr 2:129,299,610...129,309,972
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein |
CTD |
PMID:31958493 |
|
NCBI chr11:53,612,460...53,618,665
Ensembl chr11:53,602,982...53,618,669
|
|
G |
Inhbb |
inhibin beta-B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of INHBB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:119,415,463...119,422,248
Ensembl chr 1:119,415,465...119,422,248
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of INMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:55,170,627...55,174,990
Ensembl chr 6:55,170,626...55,175,043
|
|
G |
Ints7 |
integrator complex subunit 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of INTS7 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:191,575,540...191,623,690
Ensembl chr 1:191,575,636...191,623,688
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IRF7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:141,263,183...141,266,499
Ensembl chr 7:141,262,706...141,266,481
|
|
G |
Irf9 |
interferon regulatory factor 9 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IRF9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:55,603,985...55,610,030
Ensembl chr14:55,603,571...55,610,030
|
|
G |
Irgm1 |
immunity-related GTPase family M member 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IRGM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:48,865,245...48,871,420
Ensembl chr11:48,861,968...48,871,683
|
|
G |
Itgal |
integrin alpha L |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ITGAL mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:127,296,139...127,335,137
Ensembl chr 7:127,296,260...127,335,138
|
|
G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ITIH3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:30,908,572...30,923,787
Ensembl chr14:30,908,572...30,923,760
|
|
G |
Itih4 |
inter alpha-trypsin inhibitor, heavy chain 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ITIH4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:30,886,476...30,901,986
Ensembl chr14:30,886,476...30,902,353
|
|
G |
Jam3 |
junction adhesion molecule 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of JAM3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:27,097,384...27,155,421
Ensembl chr 9:27,097,384...27,155,421
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions increases expression increases phosphorylation |
EXP |
pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]; TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein] diethyl maleate results in increased expression of JUN mRNA |
CTD |
PMID:10915739 PMID:12774022 |
|
NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
|
|
G |
Kcne3 |
potassium voltage-gated channel, Isk-related subfamily, gene 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of KCNE3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:100,176,507...100,184,869
Ensembl chr 7:100,176,502...100,184,869
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of KEAP1 protein |
CTD |
PMID:27358234 |
|
NCBI chr 9:21,229,730...21,239,332
Ensembl chr 9:21,229,730...21,239,361
|
|
G |
Kifc5b |
kinesin family member C5B |
increases expression |
ISO |
diethyl maleate results in increased expression of KIFC1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:26,917,091...26,932,579
Ensembl chr17:26,917,091...26,932,583
|
|
G |
Klf10 |
Kruppel-like factor 10 |
decreases expression |
ISO EXP |
diethyl maleate results in decreased expression of KLF10 mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr15:38,291,464...38,300,711
Ensembl chr15:38,291,463...38,300,706
|
|
G |
Krt75 |
keratin 75 |
increases reduction |
EXP |
diethyl maleate results in increased reduction of KRT75 protein |
CTD |
PMID:19843705 |
|
NCBI chr15:101,563,343...101,573,904
Ensembl chr15:101,563,345...101,573,904
|
|
G |
Lama1 |
laminin, alpha 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LAMA1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:67,697,127...67,822,645
Ensembl chr17:67,697,259...67,822,647
|
|
G |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LANCL2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:57,702,455...57,739,449
Ensembl chr 6:57,702,540...57,739,439
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LDLR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:21,723,576...21,749,919
Ensembl chr 9:21,723,483...21,749,919
|
|
G |
Lepr |
leptin receptor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LEPR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:101,717,137...101,815,352
Ensembl chr 4:101,717,404...101,815,352
|
|
G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:118,392,747...118,401,959
Ensembl chr11:118,392,751...118,402,092
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
ISO |
diethyl maleate results in increased expression of LMNB1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:56,707,813...56,753,424
Ensembl chr18:56,707,813...56,753,424
|
|
G |
Lmo7 |
LIM domain only 7 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LMO7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:101,729,928...101,934,708
Ensembl chr14:101,729,957...101,934,710
|
|
G |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LRIG3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:125,966,219...126,015,359
Ensembl chr10:125,966,168...126,015,359
|
|
G |
Lrrn4 |
leucine rich repeat neuronal 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of LRRN4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:132,866,686...132,894,010
Ensembl chr 2:132,868,305...132,880,891
|
|
G |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LRTM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:119,315,133...119,332,270
Ensembl chr 6:119,315,133...119,330,766
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LTC4S mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:50,236,461...50,238,532
Ensembl chr11:50,236,461...50,238,616
|
|
G |
Lum |
lumican |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LUM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:97,565,501...97,572,703
Ensembl chr10:97,565,128...97,572,703
|
|
G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
increases expression |
ISO |
diethyl maleate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr15:79,346,621...79,359,078
Ensembl chr15:79,346,621...79,359,076
|
|
G |
Maoa |
monoamine oxidase A |
increases expression |
EXP |
diethyl maleate results in increased expression of MAOA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:16,619,698...16,687,812
Ensembl chr X:16,619,698...16,687,818
|
|
G |
Marveld1 |
MARVEL (membrane-associating) domain containing 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MARVELD1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:42,147,389...42,151,703
Ensembl chr19:42,147,400...42,151,703
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
ISO |
diethyl maleate results in increased expression of MCM10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:4,990,724...5,012,791
Ensembl chr 2:4,989,714...5,012,791
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of MCM4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:15,623,897...15,637,400
Ensembl chr16:15,623,897...15,637,400
|
|
G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
increases expression |
EXP |
diethyl maleate results in increased expression of ME1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:86,581,363...86,695,914
Ensembl chr 9:86,581,371...86,695,953
|
|
G |
Mfap4 |
microfibrillar-associated protein 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MFAP4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:61,485,431...61,488,708
Ensembl chr11:61,485,431...61,488,900
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases activity |
ISO |
diethyl maleate results in decreased activity of MGMT protein |
CTD |
PMID:16950796 |
|
NCBI chr 7:136,894,463...137,128,193
Ensembl chr 7:136,894,614...137,130,266
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
increases expression |
ISO |
diethyl maleate results in increased expression of MKI67 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:135,689,784...135,716,450
Ensembl chr 7:135,689,784...135,716,361
|
|
G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MKNK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:80,665,318...80,676,293
Ensembl chr10:80,665,327...80,678,112
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression |
EXP |
diethyl maleate results in increased expression of MMP12 mRNA |
CTD |
PMID:10216232 |
|
NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MMP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:92,827,290...92,853,421
Ensembl chr 8:92,827,291...92,853,420
|
|
G |
Msn |
moesin |
increases reduction |
EXP |
diethyl maleate results in increased reduction of MSN protein |
CTD |
PMID:19843705 |
|
NCBI chr X:96,096,045...96,168,553
Ensembl chr X:96,096,042...96,168,552
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 8:94,172,618...94,173,567
Ensembl chr 8:94,172,664...94,173,568
|
|
G |
Mx2 |
MX dynamin-like GTPase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MX1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:97,536,081...97,560,901
Ensembl chr16:97,535,308...97,560,900
|
|
G |
Mybl2 |
myeloblastosis oncogene-like 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of MYBL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:163,054,327...163,084,688
Ensembl chr 2:163,054,687...163,084,688
|
|
G |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MYCN mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:12,936,093...12,941,836
Ensembl chr12:12,936,093...12,941,914
|
|
G |
Nat8 |
N-acetyltransferase 8 (GCN5-related) |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NAT8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:85,830,387...85,836,857
Ensembl chr 6:85,830,388...85,832,082
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
increases expression |
ISO |
diethyl maleate results in increased expression of NCAPH mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:127,103,809...127,133,954
Ensembl chr 2:127,103,809...127,133,954
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
affects localization increases activity increases expression multiple interactions decreases response to substance |
EXP ISO |
diethyl maleate affects the localization of NFE2L2 protein diethyl maleate results in increased activity of NFE2L2 protein diethyl maleate results in increased expression of NFE2L2 protein diethyl maleate binds to and results in increased activity of NFE2L2 protein; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] NFE2L2 results in decreased susceptibility to diethyl maleate NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] |
CTD |
PMID:12235164 PMID:20806931 PMID:21465251 PMID:22003191 PMID:27358234 PMID:27982581 PMID:30114225 |
|
NCBI chr 2:75,675,513...75,704,663
Ensembl chr 2:75,675,513...75,704,641
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
EXP |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] |
CTD |
PMID:12774022 |
|
NCBI chr12:55,489,409...55,492,647
Ensembl chr12:55,489,410...55,492,647
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP ISO |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein] Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] |
CTD |
PMID:7532384 PMID:9918918 PMID:12774022 |
|
NCBI chr11:78,920,787...78,960,226
Ensembl chr11:78,920,787...78,960,254
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression |
ISO EXP |
diethyl maleate results in increased expression of NQO1 mRNA |
CTD |
PMID:20491607 PMID:25270620 |
|
NCBI chr 8:107,388,225...107,403,205
Ensembl chr 8:107,388,225...107,403,206
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NR0B2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:133,553,376...133,556,686
Ensembl chr 4:133,553,376...133,556,536
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NR1D1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:98,767,932...98,775,377
Ensembl chr11:98,767,932...98,775,333
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NREP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:33,437,019...33,464,365
Ensembl chr18:33,437,019...33,464,029
|
|
G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NSMF mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:25,054,361...25,062,881
Ensembl chr 2:25,054,355...25,062,881
|
|
G |
Ntf3 |
neurotrophin 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NTF3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:126,101,412...126,166,772
Ensembl chr 6:126,101,412...126,166,910
|
|
G |
Nup153 |
nucleoporin 153 |
multiple interactions affects localization |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]; diethyl maleate results in increased phosphorylation of and results in increased O-linked glycosylation of NUP153 protein |
CTD |
PMID:20041180 |
|
NCBI chr13:46,679,902...46,727,849
Ensembl chr13:46,679,905...46,727,940
|
|
G |
Nup88 |
nucleoporin 88 |
multiple interactions affects localization |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] affects the reaction [diethyl maleate affects the localization of NUP88 protein]; diethyl maleate results in increased phosphorylation of and results in increased glycosylation of NUP88 protein |
CTD |
PMID:20041180 |
|
NCBI chr11:70,943,058...70,969,973
Ensembl chr11:70,943,058...70,969,973
|
|
G |
Oaf |
out at first homolog |
decreases expression |
ISO |
diethyl maleate results in decreased expression of OAF mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:43,221,278...43,239,816
Ensembl chr 9:43,221,235...43,239,911
|
|
G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
multiple interactions |
EXP |
[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of OGG1 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 6:113,326,972...113,334,877
Ensembl chr 6:113,326,972...113,335,068
|
|
G |
Orc1 |
origin recognition complex, subunit 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of ORC1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:108,575,705...108,616,030
Ensembl chr 4:108,579,423...108,614,833
|
|
G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of P2RX7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:122,643,927...122,692,336
Ensembl chr 5:122,643,911...122,691,432
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
ISO |
diethyl maleate results in increased cleavage of PARP1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 1:180,568,891...180,600,999
Ensembl chr 1:180,568,924...180,601,254
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PBLD protein |
CTD |
PMID:21161181 |
|
NCBI chr10:63,060,625...63,077,964
Ensembl chr10:63,060,162...63,077,962
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PCNA mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 2:132,249,286...132,253,180
Ensembl chr 2:132,249,162...132,253,314
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PDLIM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:70,162,621...70,177,672
Ensembl chr14:70,164,218...70,177,681
|
|
G |
Pdrg1 |
p53 and DNA damage regulated 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of PDRG1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:153,008,890...153,016,019
Ensembl chr 2:153,008,890...153,015,427
|
|
G |
Per2 |
period circadian clock 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PER2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:91,415,977...91,459,351
Ensembl chr 1:91,415,982...91,459,324
|
|
G |
Per3 |
period circadian clock 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PER3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:150,997,018...151,044,707
Ensembl chr 4:151,003,652...151,044,665
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases activity |
ISO |
diethyl maleate results in increased activity of PGD protein |
CTD |
PMID:3099627 |
|
NCBI chr 4:149,149,991...149,166,705
Ensembl chr 4:149,149,991...149,166,771
|
|
G |
Pgrmc1 |
progesterone receptor membrane component 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of PGRMC1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:36,598,193...36,606,079
Ensembl chr X:36,598,206...36,606,079
|
|
G |
Pir |
pirin |
increases expression |
EXP |
diethyl maleate results in increased expression of PIR mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:164,269,431...164,373,013
Ensembl chr X:164,269,371...164,373,011
|
|
G |
Pklr |
pyruvate kinase liver and red blood cell |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PKLR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:89,136,122...89,146,815
Ensembl chr 3:89,136,142...89,146,784
|
|
G |
Plat |
plasminogen activator, tissue |
increases expression decreases expression |
ISO EXP |
diethyl maleate results in increased expression of PLAT mRNA diethyl maleate results in decreased expression of PLAT mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 8:22,757,722...22,782,848
Ensembl chr 8:22,757,727...22,782,844
|
|
G |
Plek |
pleckstrin |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PLEK mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:16,971,206...17,008,718
Ensembl chr11:16,971,206...17,052,381
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions decreases activity |
ISO |
diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]; resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol inhibits the reaction [diethyl maleate results in decreased activity of PPARA protein]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate results in decreased activity of PPARA protein] |
CTD |
PMID:17134953 |
|
NCBI chr15:85,734,910...85,806,851
Ensembl chr15:85,734,983...85,802,819
|
|
G |
Ppargc1b |
peroxisome proliferative activated receptor, gamma, coactivator 1 beta |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PPARGC1B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:61,291,445...61,400,756
Ensembl chr18:61,298,136...61,400,431
|
|
G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PPP1R3B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:35,375,694...35,388,139
Ensembl chr 8:35,375,739...35,388,139
|
|
G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PPP1R3C mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:36,731,731...36,736,604
Ensembl chr19:36,731,731...36,736,653
|
|
G |
Prdm14 |
PR domain containing 14 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PRDM14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:13,113,428...13,127,163
Ensembl chr 1:13,113,457...13,127,163
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
EXP ISO |
diethyl maleate results in increased expression of PRDX1 mRNA |
CTD |
PMID:9506838 |
|
NCBI chr 4:116,685,599...116,700,000
Ensembl chr 4:116,685,544...116,700,822
|
|
G |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PRKAB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:116,013,586...116,024,503
Ensembl chr 5:116,013,586...116,024,508
|
|
G |
Prkcb |
protein kinase C, beta |
affects expression |
ISO |
diethyl maleate affects the expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr 7:122,289,104...122,634,402
Ensembl chr 7:122,288,751...122,634,402
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO |
Cycloheximide inhibits the reaction [diethyl maleate results in increased expression of PRKCD protein]; diethyl maleate results in increased expression of and results in increased activity of PRKCD protein |
CTD |
PMID:11118818 |
|
NCBI chr14:30,595,353...30,626,414
Ensembl chr14:30,595,354...30,626,210
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
ISO |
Cycloheximide inhibits the reaction [diethyl maleate results in increased expression of PRKCE protein]; diethyl maleate results in increased expression of and results in increased activity of PRKCE protein |
CTD |
PMID:11118818 |
|
NCBI chr17:86,167,785...86,657,919
Ensembl chr17:86,167,785...86,657,919
|
|
G |
Prss8 |
protease, serine 8 (prostasin) |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PRSS8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:127,925,717...127,930,149
Ensembl chr 7:127,925,716...127,930,104
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of PTGR1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
|
|
G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
increases expression |
EXP |
diethyl maleate results in increased expression of PTPN14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:189,728,216...189,876,695
Ensembl chr 1:189,728,268...189,876,695
|
|
G |
Pus1 |
pseudouridine synthase 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PUS1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:110,773,667...110,780,649
Ensembl chr 5:110,773,667...110,780,659
|
|
G |
Rab27a |
RAB27A, member RAS oncogene family |
decreases expression |
ISO |
diethyl maleate results in decreased expression of RAB27A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:73,044,810...73,097,623
Ensembl chr 9:73,044,854...73,097,629
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [[carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] which results in increased glutathionylation of RELA protein]; diethyl maleate inhibits the reaction [carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] |
CTD |
PMID:20116392 |
|
NCBI chr19:5,637,442...5,648,134
Ensembl chr19:5,637,483...5,648,130
|
|
G |
Rnf114 |
ring finger protein 114 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of RNF114 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:167,492,645...167,516,173
Ensembl chr 2:167,492,645...167,516,173
|
|
G |
Rnf14 |
ring finger protein 14 |
increases expression |
EXP |
diethyl maleate results in increased expression of RNF14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:38,277,460...38,317,852
Ensembl chr18:38,284,537...38,317,849
|
|
G |
Rrm2 |
ribonucleotide reductase M2 |
increases expression |
ISO |
diethyl maleate results in increased expression of RRM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:24,708,254...24,714,146
Ensembl chr12:24,708,241...24,714,146
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of RSAD2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:26,442,743...26,456,452
Ensembl chr12:26,442,746...26,456,452
|
|
G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
decreases expression |
ISO |
diethyl maleate results in decreased expression of S100A9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:90,692,630...90,695,721
Ensembl chr 3:90,692,632...90,695,721
|
|
G |
Sash3 |
SAM and SH3 domain containing 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SASH3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:48,146,436...48,161,565
Ensembl chr X:48,146,436...48,161,565
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SCD1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:44,394,450...44,407,709
Ensembl chr19:44,394,455...44,407,879
|
|
G |
Sds |
serine dehydratase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SDS mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:120,476,547...120,483,932
Ensembl chr 5:120,476,526...120,483,932
|
|
G |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SERPINB6B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:32,956,811...32,979,067
Ensembl chr13:32,965,209...32,979,067
|
|
G |
Serpind1 |
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SERPIND1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:17,331,371...17,343,574
Ensembl chr16:17,331,371...17,343,575
|
|
G |
Sez6 |
seizure related gene 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SEZ6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:77,930,587...77,979,052
Ensembl chr11:77,930,800...77,979,048
|
|
G |
Sfxn1 |
sideroflexin 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SFXN1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:54,071,656...54,108,346
Ensembl chr13:54,071,869...54,108,342
|
|
G |
Six4 |
sine oculis-related homeobox 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of SIX4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:73,099,609...73,114,031
Ensembl chr12:73,099,609...73,113,456
|
|
G |
Slc16a6 |
solute carrier family 16 (monocarboxylic acid transporters), member 6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC16A6 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:109,450,855...109,473,598
Ensembl chr11:109,450,855...109,473,598
|
|
G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of SLC1A4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:20,302,180...20,332,713
Ensembl chr11:20,302,180...20,332,713
|
|
G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC2A2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:28,697,903...28,728,361
Ensembl chr 3:28,697,903...28,731,359
|
|
G |
Slc2a5 |
solute carrier family 2 (facilitated glucose transporter), member 5 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC2A5 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:150,119,344...150,144,168
Ensembl chr 4:150,119,283...150,144,169
|
|
G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC39A14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:70,303,467...70,351,452
Ensembl chr14:70,303,469...70,351,425
|
|
G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC40A1 mRNA] |
CTD |
PMID:21303654 |
|
NCBI chr 1:45,908,070...45,926,532
Ensembl chr 1:45,908,068...45,926,523
|
|
G |
Slc44a4 |
solute carrier family 44, member 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC44A4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:34,914,224...34,930,436
Ensembl chr17:34,914,466...34,930,436
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
multiple interactions increases expression |
EXP |
NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] |
CTD |
PMID:12235164 |
|
NCBI chr 3:50,364,936...50,499,087
Ensembl chr 3:49,892,526...50,443,614
|
|
G |
Slc9a3r1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC9A3R1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:115,163,341...115,181,178
Ensembl chr11:115,163,341...115,181,181
|
|
G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLCO2A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:103,007,061...103,096,002
Ensembl chr 9:102,988,712...103,096,002
|
|
G |
Slfn3 |
schlafen 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLFN3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:83,191,330...83,215,154
Ensembl chr11:83,191,330...83,215,154
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of SMC4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:69,004,738...69,034,623
Ensembl chr 3:69,004,738...69,034,623
|
|
G |
Smtn |
smoothelin |
increases expression |
ISO |
diethyl maleate results in increased expression of SMTN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:3,517,522...3,539,292
Ensembl chr11:3,517,523...3,540,612
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SOCS3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:117,966,079...117,970,336
Ensembl chr11:117,966,079...117,970,047
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 protein]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 protein] |
CTD |
PMID:7476933 |
|
NCBI chr17:13,007,839...13,018,119
Ensembl chr17:13,006,846...13,040,063
|
|
G |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SORL1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:41,964,709...42,124,297
Ensembl chr 9:41,964,720...42,124,297
|
|
G |
Sox9 |
SRY (sex determining region Y)-box 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of SOX9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:112,782,210...112,787,757
Ensembl chr11:112,782,224...112,787,760
|
|
G |
Sp5 |
trans-acting transcription factor 5 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SP5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:70,474,923...70,477,726
Ensembl chr 2:70,474,923...70,477,729
|
|
G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
increases expression |
ISO |
diethyl maleate results in increased expression of SPC25 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:69,193,895...69,206,213
Ensembl chr 2:69,193,895...69,206,194
|
|
G |
Spta1 |
spectrin alpha, erythrocytic 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of SPTA1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:174,172,739...174,248,449
Ensembl chr 1:174,172,776...174,248,450
|
|
G |
Sptan1 |
spectrin alpha, non-erythrocytic 1 |
increases cleavage |
ISO |
diethyl maleate results in increased cleavage of SPTAN1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 2:29,965,560...30,031,451
Ensembl chr 2:29,965,560...30,031,451
|
|
G |
Sptbn4 |
spectrin beta, non-erythrocytic 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of SPTBN4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:27,356,383...27,447,704
Ensembl chr 7:27,356,383...27,447,686
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:50,200,152...50,210,820
Ensembl chr11:50,199,366...50,210,827
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SREBF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:60,199,084...60,224,186
Ensembl chr11:60,199,089...60,222,581
|
|
G |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
multiple interactions increases expression |
EXP ISO |
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein]; TP53 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] diethyl maleate results in increased expression of SRXN1 mRNA; diethyl maleate results in increased expression of SRXN1 protein |
CTD |
PMID:22003191 PMID:25270620 PMID:27358234 PMID:27982581 |
|
NCBI chr 2:152,105,524...152,111,376
Ensembl chr 2:152,105,516...152,111,376
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of STAT1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:52,119,438...52,161,865
Ensembl chr 1:52,119,440...52,161,865
|
|
G |
Steap4 |
STEAP family member 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of STEAP4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:7,960,472...7,982,213
Ensembl chr 5:7,960,457...7,982,213
|
|
G |
Sulf2 |
sulfatase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SULF2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:166,073,899...166,155,683
Ensembl chr 2:166,073,089...166,155,663
|
|
G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SULT1A1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 7:126,672,865...126,690,443
Ensembl chr 7:126,672,865...126,676,432
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TAGLN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:45,929,628...45,936,058
Ensembl chr 9:45,929,619...45,936,058
|
|
G |
Tbcel |
tubulin folding cofactor E-like |
increases expression |
EXP |
diethyl maleate results in increased expression of TBCEL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:42,412,316...42,472,238
Ensembl chr 9:42,412,316...42,507,809
|
|
G |
Tent5a |
terminal nucleotidyltransferase 5A |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TENT5A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:85,320,439...85,327,150
Ensembl chr 9:85,320,439...85,327,348
|
|
G |
Tesmin |
testis expressed metallothionein like |
affects localization |
EXP |
diethyl maleate affects the localization of TESMIN protein |
CTD |
PMID:12606435 |
|
NCBI chr19:3,388,857...3,407,823
Ensembl chr19:3,388,857...3,407,823
|
|
G |
Tfeb |
transcription factor EB |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TFEB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:47,737,037...47,792,416
Ensembl chr17:47,737,030...47,792,419
|
|
G |
Tgm2 |
transglutaminase 2, C polypeptide |
increases expression |
ISO |
diethyl maleate results in increased expression of TGM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:158,116,405...158,146,392
Ensembl chr 2:158,116,402...158,146,436
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of THBS1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:118,111,876...118,127,133
Ensembl chr 2:118,111,876...118,127,133
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
diethyl maleate results in decreased expression of THRSP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:97,412,933...97,417,550
Ensembl chr 7:97,412,938...97,417,730
|
|
G |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of TM4SF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:57,285,611...57,387,736
Ensembl chr 3:57,285,611...57,301,988
|
|
G |
Tmem209 |
transmembrane protein 209 |
increases expression |
EXP |
diethyl maleate results in increased expression of TMEM209 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:30,481,022...30,509,787
Ensembl chr 6:30,479,053...30,509,783
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; diethyl maleate inhibits the reaction [[carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] which results in increased glutathionylation of RELA protein]; diethyl maleate inhibits the reaction [carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 protein] diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]; TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein] |
CTD |
PMID:7476933 PMID:7532384 PMID:12774022 PMID:20116392 PMID:31958493 |
|
NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
|
|
G |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TNFRSF14 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:154,918,487...154,928,620
Ensembl chr 4:154,921,933...154,928,563
|
|
G |
Tpm2 |
tropomyosin 2, beta |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TPM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:43,513,726...43,523,583
Ensembl chr 4:43,514,711...43,523,765
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
multiple interactions decreases response to substance |
ISO |
diethyl maleate inhibits the reaction [Cisplatin results in decreased expression of TRAP1 protein] TRAP1 protein results in decreased susceptibility to diethyl maleate |
CTD |
PMID:17853063 |
|
NCBI chr16:4,039,971...4,077,840
Ensembl chr16:4,039,971...4,077,827
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TRDMT1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:13,504,879...13,544,797
Ensembl chr 2:13,509,014...13,544,668
|
|
G |
Trf |
transferrin |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TF protein |
CTD |
PMID:21161181 |
|
NCBI chr 9:103,208,876...103,230,286
Ensembl chr 9:103,204,001...103,230,444
|
|
G |
Trim6 |
tripartite motif-containing 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TRIM6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:104,218,795...104,235,152
Ensembl chr 7:104,218,793...104,235,152
|
|
G |
Trip13 |
thyroid hormone receptor interactor 13 |
increases expression |
ISO |
diethyl maleate results in increased expression of TRIP13 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:73,912,450...73,937,795
Ensembl chr13:73,911,347...73,937,784
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
EXP ISO |
TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein]; TP53 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] |
CTD |
PMID:22003191 PMID:27982581 |
|
NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TSC22D1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:76,414,961...76,507,765
Ensembl chr14:76,414,961...76,507,765
|
|
G |
Tspan8 |
tetraspanin 8 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:115,816,817...115,849,893
Ensembl chr10:115,816,832...115,849,893
|
|
G |
Tstd1 |
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TSTD1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:171,419,033...171,420,352
Ensembl chr 1:171,418,872...171,420,352
|
|
G |
Txn1 |
thioredoxin 1 |
decreases activity |
ISO |
diethyl maleate results in decreased activity of TXN protein |
CTD |
PMID:15388247 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression |
ISO |
diethyl maleate results in increased expression of TXNIP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:96,557,957...96,561,857
Ensembl chr 3:96,557,957...96,561,883
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of TXNRD1 mRNA |
CTD |
PMID:15521073 |
|
NCBI chr10:82,833,951...82,897,724
Ensembl chr10:82,833,951...82,897,712
|
|
G |
Ubd |
ubiquitin D |
decreases expression |
ISO |
diethyl maleate results in decreased expression of UBD mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:37,193,892...37,196,101
Ensembl chr17:37,193,892...37,196,095
|
|
G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
increases expression |
EXP |
diethyl maleate results in increased expression of UGT2B35 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:87,000,860...87,013,274
Ensembl chr 5:87,000,860...87,013,275
|
|
G |
Uhrf1 |
ubiquitin-like, containing PHD and RING finger domains, 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of UHRF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:56,303,337...56,323,486
Ensembl chr17:56,303,321...56,323,486
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of USP18 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:121,245,906...121,270,917
Ensembl chr 6:121,245,906...121,270,917
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of USP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:44,067,021...44,095,627
Ensembl chr 9:44,067,021...44,095,627
|
|
G |
Wdr31 |
WD repeat domain 31 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of WDR31 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:62,448,653...62,470,999
Ensembl chr 4:62,448,653...62,470,896
|
|
G |
Wdr6 |
WD repeat domain 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of WDR6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:108,572,311...108,578,713
Ensembl chr 9:108,572,311...108,578,739
|
|
G |
Ypel5 |
yippee like 5 |
increases expression |
EXP |
diethyl maleate results in increased expression of YPEL5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:72,836,628...72,850,444
Ensembl chr17:72,836,453...72,851,195
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression |
ISO |
diethyl maleate results in increased expression of ZFP36 protein |
CTD |
PMID:21969073 |
|
NCBI chr 7:28,376,784...28,379,228
Ensembl chr 7:28,376,784...28,380,253
|
|
G |
Zfp367 |
zinc finger protein 367 |
increases expression |
ISO |
diethyl maleate results in increased expression of ZNF367 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:64,133,022...64,153,199
Ensembl chr13:64,133,018...64,153,202
|
|
G |
Zfp37 |
zinc finger protein 37 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ZFP37 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:62,189,537...62,209,129
Ensembl chr 4:62,189,540...62,231,047
|
|
G |
Zfp493 |
zinc finger protein 493 |
decreases reduction |
EXP |
diethyl maleate results in decreased reduction of ZFP493 protein |
CTD |
PMID:19843705 |
|
NCBI chr13:67,779,693...67,789,082
Ensembl chr13:67,779,693...67,792,512
|
|
G |
Znrd2 |
zinc ribbon domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ZNRD2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:5,730,306...5,731,732
Ensembl chr19:5,728,088...5,731,713 Ensembl chr19:5,728,088...5,731,713
|
|
|
G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30703375 |
|
NCBI chr19:34,240,336...34,255,585
Ensembl chr19:34,241,090...34,255,590
|
|
G |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
multiple interactions |
EXP |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605
|
|
G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
affects localization |
ISO |
Dimethyl Fumarate affects the localization of BACH1 protein |
CTD |
PMID:27277809 |
|
NCBI chr16:87,698,954...87,733,346
Ensembl chr16:87,698,945...87,733,346
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
multiple interactions decreases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Dimethyl Fumarate inhibits the reaction [IKBKB protein results in increased expression of CCL2 mRNA]; Dimethyl Fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to CCL2 promoter]]; Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA] Dimethyl Fumarate results in decreased expression of CCL2 mRNA |
CTD |
PMID:26683377 PMID:27277809 |
|
NCBI chr11:82,035,577...82,037,452
Ensembl chr11:82,035,571...82,037,453
|
|
G |
Cd68 |
CD68 antigen |
multiple interactions |
EXP |
Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr11:69,664,213...69,666,170
Ensembl chr11:69,664,213...69,666,153
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
EXP |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr18:61,105,572...61,131,139
Ensembl chr18:61,100,598...61,132,149
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
EXP |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr 3:95,499,210...95,509,387
Ensembl chr 3:95,499,256...95,509,362
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTH1 mRNA] Dimethyl Fumarate results in increased expression of FTH1 mRNA; Dimethyl Fumarate results in increased expression of FTH1 protein |
CTD |
PMID:28289076 |
|
NCBI chr19:9,980,600...9,985,111
Ensembl chr19:9,980,598...9,985,098
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL mRNA]; NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL protein] Dimethyl Fumarate results in increased expression of FTL mRNA; Dimethyl Fumarate results in increased expression of FTL protein |
CTD |
PMID:28289076 |
|
NCBI chr 7:45,457,944...45,459,886
Ensembl chr 7:45,457,944...45,459,884
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
EXP ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLC mRNA] Dimethyl Fumarate results in increased expression of GCLC protein |
CTD |
PMID:27277809 PMID:30248482 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
increases expression multiple interactions |
ISO EXP |
Dimethyl Fumarate results in increased expression of GCLM protein NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLM mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases metabolic processing |
ISO |
Dimethyl Fumarate results in increased metabolism of GPX4 protein |
CTD |
PMID:29917289 |
|
NCBI chr10:80,047,166...80,056,439
Ensembl chr10:80,047,166...80,056,439
|
|
G |
Gsr |
glutathione reductase |
increases expression multiple interactions |
ISO
| |